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The findings from this survey provide broad reinforcement to the themes expressed in the first phase 
interview project conducted in the Northeast region.  Overall, providers report that non-care related 
time spent with patients and on education and administrative tasks is substantial and challenging.  
Mentioned most frequently (64% of providers) was time spent with insurers for approvals and lacking 
reimbursements for medical foods and formulas. 
 
Patient care management and education was expressed as time consuming and often as a role taken on 
by providers other than medical geneticists.  Non-medical geneticists were more likely to report 
spending up to four hours monthly on the phone with families, and up to four hours on non-care related 
time monthly not insurance related.   This becomes important in that when asked what their primary 
responsibility is, most providers cited patient care, however they spent a large portion of time on non-
care activities, mostly non-reimbursed.   
 
Care coordination also varied.  Most respondents cited the use of care teams, but composition of those 
teams varied and roles were not understood.  Less than 5% of providers cited communication with 
primary care providers (PCPs) or other medical staff as primary to their responsibilities. This is despite a 
majority of providers reporting that PCPs should participate in care teams but often lack knowledge of 
the conditions.  Others reported the need to expand care teams to ease Geneticist workload and 
compensate for provider shortages.  Remote patient monitoring of some kind was also mentioned by 
84% of respondents, specifically to deal with geographic remoteness of patients. 
 
Also consistently mentioned was the lack of best practices and care guidelines, especially relative to 
expanding the NBS panel.  While providers remain sheepishly optimistic about expansions, they also 
expressed concern that the current challenges to providing care will be exacerbated.   
 
Overall a majority of respondents report having substantial work commitments to treating patients with 
metabolic disorders.  Taken together, their responses reflect an uncoordinated system of care, primarily 
related to extra-care activities.  Care process for medically treating patients was quite consistent overall.  
They are also reporting being undervalued but committed to the work of treating these patients.  Many 
reflected on the need to better integrate care, but lacked incentives or time to do so.   
 
Expansions to the NBS panel will likely not be well met if many of the administrative and educational 
concerns are not addressed.  Further, the field of metabolic genetic medicine is not well understood by 
the U.S. health care system more broadly.  With reimbursement lacking and care coordination a large 
part of national efforts to curb health spending, addressing the cost effectiveness of providing care to 
these patients will be paramount.  Developing more consistent and effective care teams and care 
process guidelines should be investigated.  This will include consistent measuring of care coordination 
time and effort to maximize reimbursement from insurers.     
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 This study proposed to assess the scope and intensity of services needed to provide quality 
genetic health care to newborns diagnosed with metabolic conditions following a positive newborn 
screen (NBS) from birth to age one across the United States.  The resources examined included time 
spent on face-to-face visits as well as non-visit time for health care providers treating these patients.  
The term ‘health care providers’ was broadly defined to include any person who works with the patient 
in an official health care capacity including clinical geneticists, dietitians/nutritionists, genetic 
counselors, patient advocates, and office/administrative staff.  Previous work on this topic in the New 
England region has shown that providing care to patients with metabolic conditions requires frequent 
visits and many non-visit hours of work.
 19
 Additionally, providers often take on responsibilities that are 
tangential to their official duties, for example, dietitians often act as care coordinators for their patients 
and families.  This project was designed based on the work in the New England region to determine if 
these patterns were evident nationally. 
Background and Rationale 
 
Newborn screening (NBS) is a state-based universally mandated core public health function that 
identifies the presence of specific disorders at birth so that treatment can begin before clinical 
symptoms present, often mitigating adverse health outcomes or death. Most of these conditions are 
inborn errors of metabolism, and therefore genetic.  With improved technologies the number of 
metabolic conditions tested on the NBS panel continues to expand.  However, these expansions 
highlight three pervasive issues within the current medical genetics workforce: (1) the workforce is 
inadequate to meet current demand for genetics services; (2) the metabolic conditions screened for on 
the NBS panel often require high intensity management; and (3) most are rare diagnoses requiring 
coordinated specialty care.   
Researchers studying the medical genetics workforce have concluded that the size of the 
current clinical genetics workforce
1,2
 and the number of students entering the field
2,3
 are inadequate to 
meet the growing demand for genetic services.  Clinical geneticists are poorly dispersed across states
1 
and a high proportion of geneticists practice in urban areas and academic medical centers,
1,4, 5, 6
  that are 
not accessible to large portions of the population who need services but live a distance away.  Clinical 
geneticists often work with a team of health care providers, including genetic counselors, whose 
workforce issues must also be addressed and understood.
1,4,5,7,8
 
One commonly cited reason for problems within the medical genetics workforce relates to 
income and reimbursement.  Reimbursement rates for genetic services are poor
1,7 
and clinical 
geneticists report low satisfaction with income and earning potential despite the fact that many clinical 




 Combined with high levels of 
labor intensity and job-related stress,
 
beginning a career in medical genetics is reported to be less 
attractive to future practitioners at a time when the demand for genetic services is growing.
 1,2,9
 
Workforce capacity is an especially salient issue for NBS because of the intensity of treatment. 
Visits for new and follow-up patients at genetics clinics for the metabolic conditions on the panel are 
lengthy, averaging 40 to 65 minutes.
1,5
 Genetics providers also spend substantial amounts of time on 
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patient care activities outside of the clinic visit: approximately three hours on average for new patient 





The labor intensity of diagnosing and treating conditions detected on NBS is counterbalanced by 
two issues.   First, according to published research, approximately 2.4 of every 1,000 live births resulted 
in the detection of a condition identified on NBS in the U.S. in 2010.
11
  Very few children actually need 
treatment; thus, it is difficult to estimate the size of the workforce needed to treat these conditions.
12
 
Second, while more conditions that have severe health and developmental consequences can be 
detected by tandem mass spectrometry, 
13, 14
 there is little to no information about the treatment or 
natural course of many of these conditions.
9,15, 16, 17
  In particular, Steiner reports that there is little 
evidence-base on the treatment of inborn errors of metabolism because there are few research 
subjects, most of these diagnoses are made at birth, and treatments may need to be individualized to 
patient-specific characteristics.
15
 Additionally, a national infrastructure for collecting this information 
was only recently developed (the NBS Translational Research Network (NBSTRN)).
18
  
 Finally, the growth of genetic medicine is changing the relationships between primary care 
providers, geneticists, and patients.  Relationships between genetic specialists and primary care 
providers would seem especially important for patients who screen positive for a metabolic condition on 
NBS.
8




NBS brings to the forefront the tenuous balance between the adequacy of the medical genetics 
workforce and the rare yet labor-intensive conditions screened for on the NBS panel.  
 
Because research to date has not directly studied the workforce needed to care for children 
diagnosed with a metabolic condition during NBS, a first phase of empirical study into this issue was 
conducted by the New England Genetics Collaborative at the University of New Hampshire for the NCC 
to examine issues of care resources being utilized for metabolic patients, as well as extra-care activities 
such as education with families, administrative tasks, and care coordination between providers.
19
   That 
study examined the process of care for children with a positive metabolic newborn screen through 
expert interviews with providers across the New England Region.    Findings suggested that the NBS 
process worked well in the states, but that resource intensity varied markedly depending on the 
condition with which the child was diagnosed.  Also found was that care coordination was lacking both 
between treating providers and primary care providers and the metabolic team, and that the roles of 
care teams were often diverse and not well understood or communicated.  Educational and 
administrative burden was also found to be substantial.  Many providers believed that while there is 
potentially great promise from enhanced metabolic screening, the workload and process issues that 




 These findings provide an important empirical window into the care process for metabolic 
patients broadly defined.  It was, however, conducted on a limited geographic sample of providers in the 
Northeast.  Further data collection was warranted to understand if similar issues were being 
experienced in other parts of the country.  For this reason, a larger national survey was developed as a 






 Similar to phase one, the phase two survey sought to define the process of care for newborns 
diagnosed with metabolic conditions after positive newborn screens (NBS) from birth to age one based 
on reports from a national sample of health care providers who treat such patients.  Metabolic 
conditions were selected because they provide a more definable treatment protocol than some other 
disorders on the NBS panel and thus allow for more accurate empirical measurement of the resources 
needed to treat those patients.  Additionally, it examined the amount of time that providers spent 
working on these patients’ cases outside of visit time, potential challenges to providing care, and 
attitudes about an expanded NBS panel.  These topics were defined based on the phase one interview 
project conducted during 2010.  
In order to assess these factors at the national level, an online survey was created.  In addition 
to the phase one findings, input into the survey was sought from the regional collaboratives nationwide.  
Those in the West and Midwest cited the use of telemedicine and access as additional areas of interest 
for inclusion in the survey.  The final tool, found in Appendix A, contained seventy-four questions and 
was deployed by the University of New Hampshire Survey Center.  The survey opened on September 28, 
2011 and closed on May 1, 2012.  Participants were recruited in two stages.  First, potential participants 
were contacted through the Regional Genetic and Newborn Screening Service Collaboratives. Second, 
participants were recruited via professional organizations, conferences, and networks.  Potential 
participants were contacted electronically by the National Coordinating Center for the Regional Genetic 
and Newborn Screening Service Collaboratives (NCC), the Society for Inherited Metabolic Disorders 
(SIMD), the NBS mailing list (Newborn Screening Inquiry/Discussion List) by Dr. Brad Therrell 
(NBS@lists.UTSCSA.edu), and the Pediatric and Clinical Genetics special interest group listserv of the 
National Society of Genetic Counselors (NSGC).  Finally, the survey was made available electronically and 
in paper format at the American College of Medical Genetics (ACMG) Annual Clinical Genetics Meetings 
(March 27-31, 2012) and the Genetic Metabolic Dietitians International (GMDI) Educational Conference 
(April 19-21, 2012).  The sampling methodology is detailed in Appendix B. 
 Analyses were conducted using Stata 11.  The analyses created for this report are based on the 
114 usable surveys that were submitted.  Sample sizes vary for each section of the survey because of 
skip patterns and missing data; respondents who responded to at least one question in a given section 
were included in that section’s analysis.  The final sample contained 67 clinical geneticists and 47 other 
(non-clinical geneticist) providers.  Process of care and non-visit administrative time analyses were 
calculated separately for clinical geneticists and all other providers.  Significance tests were not 
calculated because of thin cells.  Providers were invited to write-in comments about ‘best practices’ and 
other concerns not covered by the survey at the end of the survey.  These comments have been coded 








Summary of Findings 
 
 The sections below represent a summary of the key findings from each area of the survey.  
Detailed analyses are presented in the following section.   
Care Process  
 
The intensity of services provided to newborns with metabolic conditions detected on NBS can be 
described by the frequency, length, and duration of contact between patients/families and providers. 
o Providers are in contact – via telephone and face-to-face visits – with patients and their families 
very soon after a metabolic condition is detected on NBS.   
o Providers are in contact with patients frequently during the first year of life.  Although metabolic 
disorders vary, providers seem to have frequent contact with patients who have any type of 
metabolic disorder. 
o Providers see patients less frequently as patients get older during the first year of life. 
 
Clinical geneticists and other providers have similar rates of contact with providers for most disorder 
categories.  However, for some metabolic conditions, for example, amino acid disorders, other providers 
reported more frequent visits with patients/families than did clinical geneticists.   
Non-Visit Administrative Time 
 
Administrative tasks, such as talking on the phone with families, doing case management, interacting 
with insurance companies, and preparing for face-to-face visits, were reported as time-consuming tasks. 
 
Differences were evident by provider type: other providers more frequently reported spending more 
time on the phone with families, doing case management, preparing for face-to-face visits, working with 
insurance companies, and on other tasks than did clinical geneticists. 
 
The most time-intensive reasons that providers reported were related to insurance; specifically 
approvals for medical foods and formulas, approvals for medications, and general reimbursement for 
services. 
Care Coordination and Models of Care Provision 
 
Providers reported many responsibilities for patients.  Providers most frequently reported being 
responsible for managing medical needs and educating patients and families.  Other providers 
frequently reported coordinating care for patients and families. 
 
Different models of care provision were used by providers’ clinics to address patient needs; most 
important was using a team approach to care.  Providers also frequently reported using satellite clinics 
and using telemedicine technologies. 
Challenges to Providing Care 
 
Practitioners reported that their ability to provide care during the first year of life is primarily made 
challenging by the lack of reimbursement for patient care.  Other factors, such as parental/familial 
knowledge and awareness of the disorder, compliance with treatment and management protocols were 
considered somewhat challenging. 
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However, some factors were considered less challenging.  Specifically, providers’ contact with state NBS 
or follow-up programs, the ability to transition patients to hospital providers, and the practitioners’ own 
educational needs concerning metabolic disorders were not considered challenging. 
Education 
 
Providers reported spending substantial amounts of time educating families about metabolic conditions.  
Families needed to be educated about the treatment and management of the disorders in addition to 
other basic information.   
 
Providers mainly used pamphlets, resource binders, and websites to educate their patients and families.  
Families, providers reported, only sometimes had accurate information about metabolic disorders when 
they came into the provider’s practice. 
Relationships with Primary Care Providers 
 
Metabolic providers reported that relationships with primary care providers were important and that 
primary care providers should participate in the care of patients with metabolic conditions, despite what 
was perceived as a lack of knowledge about these conditions.   
Attitudes about Expanding the Newborn Screening Panel 
 
Providers seemed cautiously optimistic about expanding the NBS panel.  While they were excited to 
treat children whose conditions would otherwise go undetected, they remain concerned about the 
number of trained providers, the ability to spend enough time with new patients, and about being 
reimbursed for care provided. 
 
Detailed Analysis and Findings 
 
 Detailed analytic findings are presented below.  They have been divided topically for clarity.  




 The final sample contained a total of 114 cases with usable data, as shown in Table 1.  The 
majority of respondents were clinical geneticists (59%).  Because one of the goals of this project was to 
assess processes of care for all providers, the sample was divided based on provider type: clinical 
geneticists versus all other providers.  The majority of other providers were dietitians/nutritionists 
(38%), genetic counselors (21%), and ‘other’ providers (21%).  These ‘other’ providers include nurse 
practitioners, neurologists, and lab directors, among others. 
 The majority of providers (60%) stated that less than 40% of their practice was dedicated to 
treating children diagnosed with metabolic conditions following a positive NBS from birth to age one.  
Eleven percent reported that at least 90% of their practice was composed of these children.  Nearly two-
thirds of clinical geneticists (63%) reported that less than 30% of their practice was composed of these 
children, compared to 28% of other providers.  Other providers were most likely (26%) to report that at 
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least 90% of their practice was dedicated to treating children diagnosed with metabolic conditions 
following a positive NBS. 
 At least 90% of all providers reported treating children with each of the three types of metabolic 
disorders on the NBS panel – organic acid disorders (90%), fatty acid oxidation disorders (94%), amino 
acid disorders (93%).  Eighty-nine percent of all providers reported treating children with all of these 
types of disorders.  Clinical geneticists were most likely to report that they treated children with fatty 
acid oxidation disorders (97%), while other providers were most likely to report that they treated 
children with amino acid disorders (92%).   
 Respondents were asked to provide their zip code so that processes of care could be assessed 
regionally.  Most providers (33%) did not report their zip codes and could thus not be assigned to a 
region.  However, providers who were able to be assigned to a region were spread rather evenly across 
the United States.  This remained consistent for clinical geneticists and other providers. 
 
Table 1. Respondent Characteristics
1
 
      Provider Type 







Provider Type #1       
  Clinical Geneticist 58.77% (67) 100% (67) - 
  Dietitian/Nutritionist 15.79 (18) - 38.30 (18) 
  Social Worker 0.88 (1) - 2.13 (1) 
  Nurse 2.65 (3) - 6.38 (3) 
  Patient Advocate 0.88 (1) - 2.13 (1) 
  Office/Administrative Manager 2.63 (3) - 6.38 (3) 
  Genetic Counselor 8.77 (10) - 21.28 (10) 
  Primary Care Provider 0.88 (1) - 2.13 (1) 
  Other 8.77 (10) - 21.28 (10) 
Percentage of Practice Dedicated to These Children       
  0-10% 12.28 (14) 17.91 (12) 4.26 (2) 
  11-20% 21.05 (24) 23.88 (16) 17.02 (8) 
  21-30% 14.91 (17) 20.90 (14) 6.38 (3) 
  31-40% 11.40 (13) 11.94 (8) 10.64 (5) 
  41-50% 6.14 (7) 5.97 (4) 6.38 (3) 
  51-60% 7.02 (8) 7.46 (5) 6.38 (3) 
  61-70% 4.39 (5) 5.97 (4) 2.13 (1) 
  71-80% 1.75 (2) 1.49 (1) 2.13 (1) 
  81-90% 4.39 (5) 1.49 (1) 8.51 (4) 
  91-100% 11.40 (13) 1.49 (1) 25.53 (12) 
  Not Reported 5.26 (6) 1.49 (1) 10.64 (5) 
Providers Treat Children Diagnosed with…       
  Organic Acid Disorders 90.35 (103) 94.03 (63) 85.11 (40) 
  Fatty Acid Oxidation Disorders 93.86 (107) 97.01 (65) 89.36 (42) 
  Amino Acid Disorders 92.98 (106) 94.03 (63) 91.49 (43) 
U.S. Census Region       
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  Northeast 17.54 (20) 17.91 (12) 17.02 (8) 
  South 17.54 (20) 17.91 (12) 17.02 (8) 
  Midwest 14.04 (16) 10.45 (7) 19.15 (9) 
  West 18.42 (21) 19.40 (13) 17.02 (8) 
  Not Reported 32.46 (37) 34.33 (23) 29.79 (14) 
1
Column percentages are shown. 
 
2. Processes of Care 
 
 In order to assess the scope and intensity of services provided to patients, this project 
distinguished between three categories of metabolic disorders: organic acid disorders, fatty acid 
oxidation disorders, and amino acid disorders.  While there is substantial variation within each category 
of disorder, these categories serve to identify the different disorders and treatment protocols 
appropriate to each type of disorder.  Additionally, as one provider stated in the Best Practices section 
of the survey, processes of care vary by “unique factors (insurance, level of education/understanding, 
geographic location, etc.)” it can be difficult to “generalize a specific plan to all patients.”  The following 
analyses identify the disorder category and associated process of care.  For each category of disorder, 
providers were asked to indicate the individual disorders they saw most commonly in their practice and 
the length and frequency of initial and follow-up visits and phone calls. 
 
Organic Acid Disorders 
 
 Among the 103 respondents who reported that they treated children diagnosed with organic 
acid disorders following positive NBS, only 94 answered any questions regarding the specific conditions 
they saw or services they provided.  The results presented below reflect the reports of those 94 
respondents. 
 As shown in Table 2a, the most frequently reported organic acid disorders seen in practice were 
Priopionic Academia (PROP; 66%) and Methylmalonic Acidemia (Methylmalonyl-CoA Mutase) (MUT; 
62%).  Providers also frequently reported 3-Methylcrotonyl-CoA Carboxylase Deficiency (3-MCC; 42%), 
Glutaric Acidemia Type I (GA1; 40%), and Methylmalonic Acidemia (Cobalamin Disorders) (Cbl, A, B; 
37%).  This pattern remained the same for clinical geneticists.  Among other providers, Propionic 
Acidemia (PROP; 68%) was the most frequently reported disorder, followed by Methylmalonic Acidemia 
(Methylmalonyl-CoA Mutase) (MUT; 50%) and Isovaleric Acidemia (IVA; 42%). 
 
Table 2a. Organic Acid Disorders Most Often Seen in Practice 








Propionic Academia (PROP) 65.96 (62) 64.29 (36) 68.42 (26) 
Methylmalonic Acidemia (Methylmalonyl-CoA Mutase) (MUT) 61.70 (58) 69.64 (39) 50.00 (19) 
Methylmalonic Acidemia (Cobalamin Disorders) (Cbl, A, B) 37.23 (35) 37.50 (21) 36.84 (14) 
Isovaleric Acidemia (IVA) 29.79 (28) 21.43 (12) 42.11 (16) 
3-Methylcrotonyl-CoA Carboxylase Deficiency (3-MCC) 41.49 (39) 42.86 (24) 39.47 (15) 
3-Hydroxy-3-Methyglutaric Aciduria (HMG) 2.13 (2) 3.57 (2) 0.00 (0) 
Holocarboxylase Synthase Deficiency (MCD) 3.19 (3) 3.57 (2) 2.63 (1) 
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B-Ketothiolase Deficiency (BKT) 3.19 (3) 1.79 (1) 5.26 (2) 
Glutaric Acidemia Type I (GA1) 40.43 (38) 44.64 (25) 35.21 (13) 
 
 Table 2b contains providers’ reports of the frequency, timing, and duration of visits for children 
diagnosed with organic acid disorders during the first year of life.  More than half of providers reported 
talking to the patient’s family on the phone the same day or day after a positive NBS.  An additional 30% 
make this phone call within one week of the detection of an organic acid disorder.  While most clinical 
geneticists and other providers reported talking on the phone with patients’ families within one week, 
clinical geneticists were more likely than other providers to report that this first phone call occurred the 
day of or day after positive NBS.  This first phone call usually lasts less than one hour (88%).   
 The first patient visit was also reported to occur quickly.  Thirty percent of providers reported 
seeing patients with positive NBS the same day or the day after an abnormal NBS; an additional 45% 
reported seeing patients within one week of the abnormal blood result.  Clinical geneticists more 
frequently reported seeing patients sooner (within the week) than other providers, who were most 
likely to report seeing patients within two weeks (68%) of the abnormal blood result.  This first visit was 
lengthy.  More than 75% of providers reported that the first visit lasted between one and two hours; an 
additional 17% reported that it lasted between two and four hours.  The length of the first visit was 
similar among clinical geneticists and other providers. 
 After these initial contacts, patients were seen less frequently by providers over the course of 
the first year of life.  During the first month, approximately 60% of providers reported seeing patients 
between weekly and a few times per month.  During months two and three, patients were reported to 
visit providers between a few times a month (27%) and once a month (37%).  During months four 
through six, providers reported that they saw patients between once a month (37%) and once every 
couple of months (45%).  Finally, during months seven through twelve, 75% of providers reported that 
they saw patients with organic acid disorders every couple of months.  These follow-up visits were also 
lengthy.  Approximately 70% of providers reported that these visits lasted between 30 minutes and 1 
hour.  The reported frequency and duration of follow-up visits was similar for clinical geneticists and 
other providers. 
 
Table 2b. Process of Care for Children Treated for Organic Acid Disorders
1
 
        Provider Type 





First Phone Call       
  The Same or Next Day 52.13 (49) 66.07 (37) 31.58 (12) 
  Within the Week 28.72 (27) 19.64 (11) 42.11 (16) 
  Within Two Weeks 7.45 (7) 3.57 (2) 13.16 (5) 
  Within the Month 5.32 (5) 5.36 (3) 5.26 (2) 
  Within Six Months 1.06 (1) 0.00 (0) 2.63 (1) 
  Not Reported 5.32 (5) 5.36 (3) 5.26 (2) 
Length of First Phone Call       
  Less than 1 Hour 88.30 (83) 83.93 (47) 94.74 (36) 
  1-2 Hours 6.38 (6) 10.71 (6) 0.00 (0) 
  Not Reported 5.32 (5) 5.36 (3) 5.26 (2) 
First Patient Visit       
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  The Same or Next Day 29.79 (28) 37.50 (21) 18.42 (7) 
  Within the Week 44.68 (42) 47.43 (26) 42.11 (16) 
  Within Two Weeks 17.02 (16) 10.71 (6) 26.32 (10) 
  Within the Month 5.32 (5) 3.57 (2) 7.89 (3) 
  Within Six Months 1.06 (1) 0.00 (0) 2.63 (1) 
  Not Reported 2.13 (2) 1.79 (1) 2.63 (1) 
Length of First Visit       
  Less than 1 Hour 4.26 (4) 5.36 (3) 2.63 (1) 
  1-2 Hours 76.60 (72) 75.00 (42) 78.95 (30) 
  2-4 Hours 17.02 (16) 17.86 (10) 15.79 (6) 
  Not Reported 2.13 (2) 1.79 (1) 2.63 (1) 
Frequency of Follow-Up Visits       
  First Month       
    More than Once a Week 3.19 (3) 3.57 (2) 2.63 (1) 
    Once a Week 30.85 (29) 32.14 (18) 28.95 (11) 
    2-3 Times per Month 31.91 (30) 30.36 (17) 34.21 (13) 
    Once a Month 22.34 (21) 26.79 (15) 15.79 (6) 
    Every Couple of Months 5.32 (5) 5.36 (3) 5.26 (2) 
    Never 3.19 (3) 0.00 (0) 7.89 (3) 
    Not Reported 3.19 (3) 1.79 (1) 5.26 (2) 
  Months 2-3       
    Once a Week 5.32 (5) 3.57 (2) 7.89 (3) 
    2-3 Times per Month 26.60 (25) 23.21 (13) 31.58 (12) 
    Once a Month 37.23 (35) 42.86 (24) 28.95 (11) 
    Every Couple of Months 21.28 (20) 21.43 (12) 21.05 (8) 
    Never 2.13 (2) 0.00 (0) 5.26 (2) 
    Not Reported 7.45 (7) 8.93 (5) 5.26 (2) 
  Months 4-6       
    2-3 Times per Month 11.70 (11) 8.93 (5) 15.79 (6) 
    Once a Month 37.23 (35) 39.29 (22) 34.21 (13) 
    Every Couple of Months 44.68 (42) 46.43 (26) 42.11 (16) 
    Not Reported 6.38 (6) 5.36 (3) 7.89 (3) 
  Months 7-12       
    2-3 Times per Month 2.13 (2) 1.79 (1) 2.63 (1) 
    Once a Month 17.02 (16) 12.50 (7) 23.68 (9) 
    Every Couple of Months 74.47 (70) 80.36 (45) 65.79 (25) 
    Not Reported 6.38 (6) 5.36 (3) 7.89 (3) 
Length of Follow-Up Visits       
  15-30 Minutes 12.77 (12) 16.07 (9) 7.89 (3) 
  30-45 Minutes 40.43 (38) 33.93 (19) 50.00 (19) 
  45 Minutes-1 Hour 28.72 (27) 28.57 (16) 28.95 (11) 
  More than 1 Hour 15.96 (15) 19.64 (11) 10.53 (4) 
  Not Reported 2.13 (2) 1.79 (1) 2.63 (1) 
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1
Column percentages are shown. 
 
Fatty Acid Oxidation Disorders 
 
 Among the 107 respondents who reported that they treated children diagnosed with fatty acid 
oxidation disorders following positive NBS, only 92 answered any questions regarding the specific 
conditions they saw or services they provided.  The results presented below reflect the reports of those 
92 respondents. 
 As shown in Table 2c, the most frequently reported fatty acid oxidation disorders were Medium-
Chain Acyl-CoA Dehydrogenase Deficiency (MCAD; 94%) and Very Long-Chain Acyl-CoA Dehydrogenase 
Deficiency (VLCAD; 85%).  These were also the most commonly reported conditions for clinical 
geneticists and other providers. 
 
Table 2c. Fatty Acid Oxidation Disorders Most Often Seen in Practice 








Carnitine Uptake Defect/Carnitine Transport Defect (CUD) 50.00 (46) 61.11 (33) 34.21 (13) 
Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD) 93.48 (86) 96.30 (52) 89.47 (34) 
Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD) 84.78 (78) 83.33 (45) 86.84 (33) 
Long-Chain L-3 Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD) 34.78 (32) 31.48 (17) 39.47 (15) 
Trifunctional Protein Deficiency (TFP) 6.52 (6) 3.70 (2) 10.53 (4) 
 
 Table 2d contains providers’ reports of the frequency, timing, and duration of visits for children 
diagnosed with fatty acid oxidation disorders during the first year of life.  Nearly half of providers 
reported talking to the patient’s family on the phone the same day or day after a positive NBS.  An 
additional 33% make this phone call within one week of the detection of a fatty acid oxidation disorder.  
While most clinical geneticists and other providers reported talking on the phone with patients’ families 
within one week, clinical geneticists were more likely than other providers to report that this first phone 
call occurred the day of or day after positive NBS.  This first phone call usually lasts less than one hour 
(84%); this was similar for clinical geneticists and other providers.   
 The first patient visit was also reported to occur quickly.  Twenty percent of providers reported 
seeing patients with positive NBS the same day or the day after an abnormal NBS; 46% reported seeing 
patients within one week of the abnormal blood result; and 26% reported seeing patients within two 
weeks.  The timing of this first visit was similar for clinical geneticists and other providers.  This first visit 
was lengthy.  Eighty percent of providers reported that the first visit lasted between one and two hours; 
an additional 11% reported that it lasted between two and four hours.  The length of the first visit was 
similar among clinical geneticists and other providers. 
 After these initial contacts, patients were seen less frequently by providers over the course of 
the first year of life.  During the first month, approximately 40% of providers reported seeing patients 
once a month.  During months two and three, patients were reported to visit providers between once a 
month (32%) and every couple of months (37%).  Between months 4 and 12, most providers reported 
that they saw patients once every couple of months.  Most providers (41%) reported that follow-up 
visits lasted between 30 and 45 minutes, and an additional 30% reported follow-up visits lasting 45 
minutes to 1 hour.  The reported frequency and duration of follow-up visits was similar for clinical 
geneticists and other providers. 
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Table 2d. Process of Care for Children Treated for Fatty Acid Oxidation Disorders
1
 
        Provider Type 







First Phone Call       
  The Same or Next Day 47.83 (44) 61.11 (33) 28.95 (11) 
  Within the Week 32.61 (30) 25.93 (14) 42.11 (16) 
  Within Two Weeks 8.70 (8) 5.56 (3) 13.16 (5) 
  Within the Month 5.43 (5) 1.85 (1) 10.53 (4) 
  Not Reported 5.43 (5) 5.56 (3) 5.26 (2) 
Length of First Phone Call       
  Less than 1 Hour 83.70 (77) 81.48 (44) 89.84 (33) 
  1-2 Hours 9.78 (9) 12.96 (7) 5.26 (2) 
  Not Reported 6.52 (6) 5.56 (3) 7.89 (3) 
First Patient Visit       
  The Same or Next Day 19.57 (18) 22.22 (12) 15.79 (6) 
  Within the Week 45.65 (42) 48.15 (26) 42.11 (16) 
  Within Two Weeks 26.09 (24) 24.07 (13) 28.95 (11) 
  Within the Month 5.43 (5) 3.70 (2) 7.89 (3) 
  Not Reported 3.26 (3) 1.85 (1) 5.26 (2) 
Length of First Visit       
  Less than 1 Hour 5.43 (5) 7.41 (4) 2.63 (1) 
  1-2 Hours 80.43 (74) 77.78 (42) 84.21 (32) 
  2-4 Hours 10.87 (10) 12.96 (7) 7.89 (3) 
  Not Reported 3.26 (3) 1.85 (1) 5.26 (2) 
Frequency of Follow-Up Visits       
  First Month       
    More than Once a Week 4.35 (4) 3.70 (2) 5.26 (2) 
    Once a Week 18.48 (17) 22.22 (12) 13.16 (5) 
    2-3 Times per Month 21.74 (20) 18.52 (10) 26.32 (10) 
    Once a Month 40.22 (37) 46.30 (25) 31.58 (12) 
    Every Couple of Months 9.78 (9) 7.41 (4) 13.16 (5) 
    Never 1.09 (1) 0.00 (0) 2.63 (1) 
    Not Reported 4.35 (4) 1.85 (1) 7.89 (3) 
  Months 2-3       
    Once a Week 4.35 (4) 3.70 (2) 5.26 (2) 
    2-3 Times per Month 15.22 (14) 16.67 (9) 13.16 (5) 
    Once a Month 31.52 (29) 29.63 (16) 34.21 (13) 
    Every Couple of Months 36.96 (34) 40.74 (22) 31.58 (12) 
    Not Reported 11.96 (11) 9.26 (5) 15.79 (6) 
  Months 4-6       
    2-3 Times per Month 5.43 (5) 7.41 (4) 2.63 (1) 
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    Once a Month 29.35 (27) 25.93 (14) 34.21 (13) 
    Every Couple of Months 58.70 (54) 61.11 (33) 55.26 (21) 
    Not Reported 6.52 (6) 5.56 (3) 7.89 (3) 
  Months 7-12       
    2-3 Times per Month 1.09 (1) 1.85 (1) 0.00 (0) 
    Once a Month 7.61 (7) 5.56 (3) 10.53 (4) 
    Every Couple of Months 84.78 (78) 87.04 (47) 81.58 (31) 
    Not Reported 6.52 (6) 5.56 (3) 7.89 (3) 
Length of Follow-Up Visits       
  15-30 Minutes 10.87 (10) 9.26 (5) 13.16 (5) 
  30-45 Minutes 41.30 (38) 35.19 (19) 50.00 (19) 
  45 Minutes-1 Hour 30.43 (28) 33.33 (18) 26.32 (10) 
  More than 1 Hour 13.04 (12) 16.67 (9) 7.89 (3) 
  Not Reported 4.35 (4) 5.56 (3) 2.63 (1) 
1
Column percentages are shown. 
 
Amino Acid Disorders 
 
 Among the 106 respondents who reported that they treated children diagnosed with amino acid 
disorders following positive NBS, only 89 answered any questions regarding the specific conditions they 
saw or services they provided.  The results presented below reflect the reports of those 89 respondents. 
 As shown in Table 2e, the most frequently reported amino acid disorder was Classic 
Phenylketonuria (PKU; 94%).  Nearly half of providers also reported frequently treating children with 
Maple Syrup Urine Disease (MSUD).  These findings were similar for clinical geneticists and other 
providers. 
 
Table 2e. Amino Acid Disorders Most Often Seen in Practice 








Argininosuccinic Aciduria (ASA) 39.33 (35) 41.18 (21) 36.84 (14) 
Citrullinemia, Type I (CIT) 38.20 (34) 43.14 (22) 31.58 (12) 
Maple Syrup Urine Disease (MSUD) 49.44 (44) 50.98 (26) 47.37 (18) 
Homocystinuria (HCY) 34.83 (31) 33.33 (17) 36.84 (14) 
Classic Phenylketonuria (PKU) 94.38 (84) 96.08 (49) 92.11 (35) 
Tyrosinemia, Type I (TYR I) 14.61 (13) 13.73 (7) 15.79 (6) 
 
 Table 2f contains providers’ reports of the frequency, timing, and duration of visits for children 
diagnosed with amino acid disorders during the first year of life.  Sixty-three percent of providers 
reported talking to the patient’s family on the phone the same day or day after a positive NBS.  An 
additional 18% make this phone call within one week of the detection of an amino acid disorder.  Most 
clinical geneticists reported talking on the phone with patients’ families the day of or after an amino acid 
disorder was detected; among other providers, 45% reported talking to patients’ families the same or 
next day and 29% reported talking to families within a week of the condition’s detection.  This first 
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phone call usually lasts less than one hour (80%); this was similar for clinical geneticists and other 
providers.   
 The first patient visit was also reported to occur quickly.  Thirty-seven percent of providers 
reported seeing patients with positive NBS the same day or the day after an abnormal NBS and an 
additional 44% reported seeing patients within one week of the abnormal blood result.  Fifty-one 
percent of clinical geneticists reported seeing the patient for the first time the same or next day; an 
additional 39% reported seeing the patient within one week of the abnormal NBS.  Other providers saw 
patients less quickly; 21% of other providers saw patients within two weeks of the detection of the 
amino acid disorder.  This first visit was lengthy.  Seventy-three percent of providers reported that the 
first visit lasted between one and two hours; an additional 21% reported that it lasted between two and 
four hours.  The length of the first visit was similar among clinical geneticists and other providers. 
 After these initial contacts, patients were seen less frequently by providers over the course of 
the first year of life.  During the first three months, providers reported seeing patients once a month.  
Between months 4 and 12, most providers reported that they saw patients once every couple of 
months.  The timing of visits differed between clinical geneticists and other providers.  While most 
clinical geneticists reported seeing patients once a week during the first month, (41%), once a month 
during months two through three (37%), and every couple of months during months four through 12, 
other providers reported seeing patients more frequently.  During the first month, other providers 
reported seeing patients between once a week (29%) and a few times per month (32%).  Other 
providers also frequently reported seeing patients a few times a month (32%) during months two and 
three and between once a month (37%) and every couple of months (40%) during months four through 
six.  During months seven through twelve, other providers most frequently reported seeing patients 
every couple of months (66%).  Most providers (46%) reported that follow-up visits lasted between 30 
and 45 minutes, and an additional 29% reported follow-up visits lasting 45 minutes to 1 hour.  The 
reported duration of follow-up visits was similar for clinical geneticists and other providers. 
 
Table 2f. Process of Care for Children Treated for Amino Acid Disorders
1
 
        Provider Type 







First Phone Call       
  The Same or Next Day 62.92 (56) 76.47 (39) 44.74 (17) 
  Within the Week 17.98 (16) 9.80 (5) 28.95 (11) 
  Within Two Weeks 11.24 (10) 7.84 (4) 15.79 (6) 
  Within the Month 2.25 (2) 1.96 (1) 2.63 (1) 
  Not Reported 5.62 (5) 3.92 (2) 7.89 (3) 
Length of First Phone Call       
  Less than 1 Hour 79.78 (71) 78.43 (40) 81.58 (31) 
  1-2 Hours 14.61 (13) 17.65 (9) 10.53 (4) 
  Not Reported 5.62 (5) 3.92 (2) 7.89 (3) 
First Patient Visit       
  The Same or Next Day 37.08 (33) 50.98 (26) 18.42 (7) 
  Within the Week 43.82 (39) 39.22 (20) 50.00 (19) 
  Within Two Weeks 14.61 (13) 9.80 (5) 21.05 (8) 
  Within the Month 2.25 (2) 0.00 (0) 5.26 (2) 
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  Within Six Months 1.12 (1) 0.00 (0) 2.63 (1) 
  Not Reported 1.12 (1) 0.00 (0) 2.63 (1) 
Length of First Visit       
  Less than 1 Hour 4.49 (4) 5.88 (3) 2.63 (1) 
  1-2 Hours 73.03 (65) 72.55 (37) 73.68 (28) 
  2-4 Hours 21.35 (19) 21.57 (11) 21.05 (8) 
  Not Reported 1.12 (1) 0.00 (0) 2.63 (1) 
Frequency of Follow-Up Visits       
  First Month       
    More than Once a Week 5.62 (5) 3.92 (2) 7.89 (3) 
    Once a Week 35.96 (32) 41.18 (21) 28.95 (11) 
    2-3 Times per Month 25.84 (23) 21.57 (11) 31.58 (12) 
    Once a Month 23.60 (21) 29.41 (15) 15.79 (6) 
    Every Couple of Months 4.49 (4) 3.92 (2) 5.26 (2) 
    Never 2.25 (2) 0.00 (0) 5.26 (2) 
    Not Reported 2.25 (2) 0.00 (0) 5.26 (2) 
  Months 2-3       
    Once a Week 11.24 (10) 9.80 (5) 13.16 (5) 
    2-3 Times per Month 26.97 (24) 23.53 (12) 31.58 (12) 
    Once a Month 32.58 (29) 37.25 (19) 26.32 (10) 
    Every Couple of Months 19.10 (17) 19.61 (10) 18.42 (7) 
    Never 2.25 (2) 0.00 (0) 5.26 (2) 
    Not Reported 7.87 (7) 9.80 (5) 5.26 (2) 
  Months 4-6       
    Once a Week 3.37 (3) 3.92 (2) 2.63 (1) 
    2-3 Times per Month 16.85 (15) 19.61 (10) 13.16 (5) 
    Once a Month 32.58 (29) 29.41 (15) 36.84 (14) 
    Every Couple of Months 41.57 (37) 43.14 (22) 39.47 (15) 
    Never - - - 
    Not Reported 5.62 (5) 3.92 (2) 7.89 (3) 
  Months 7-12       
    2-3 Times per Month 6.74 (6) 9.80 (5) 2.63 (1) 
    Once a Month 17.98 (16) 13.73 (7) 23.68 (9) 
    Every Couple of Months 68.54 (61) 70.59 (36) 65.79 (25) 
    Not Reported 6.74 (6) 5.88 (3) 7.89 (3) 
Length of Follow-Up Visits       
  15-30 Minutes 4.49 (4) 3.92 (2) 5.26 (2) 
  30-45 Minutes 46.07 (41) 43.14 (22) 50.00 (19) 
  45 Minutes-1 Hour 29.21 (26) 27.45 (14) 31.58 (12) 
  More than 1 Hour 17.98 (16) 23.53 (12) 10.53 (4) 
  Not Reported 2.25 (2) 1.96 (1) 2.63 (1) 
1




3. Non-Visit Administrative Time 
 
 All providers and office/administrative staff were asked to estimate the amount of time that 
they personally spent outside of the face-to-face visit doing, for example, case management and 
preparing for face-to-face visits, per month.  These questions were asked once, not separately for the 
three categories of metabolic disorders identified on NBS described above.  The time spent on 
administrative tasks has been separated based on provider type to reflect the responsibilities of clinical 
geneticists and other providers.  A total of 93 respondents answered at least one question about the 
amount of time they spent on non-visit administrative tasks. 
 Table 3a shows the amount of time that providers spent on the administrative tasks.  Nearly 
30% of providers reported spending less than 30 minutes on the phone with the family of a patient with 
a metabolic disorder per month.  One quarter of providers stated that they spent between thirty 
minutes and one hour on the phone with families each month, while an additional 22% reported 
spending between one and two hours on the phone each month.  Eight percent of all providers reported 
that talking to the family on the phone was not one of their administrative responsibilities.  Differences 
in time spent on the telephone were evident by provider type.  Clinical geneticists were more likely than 
other providers to report spending less than 30 minutes on the phone with families while other 
providers were more likely than clinical geneticists to report spending between two and four hours per 
month on the phone with families. 
 Providers reported spending a substantial amount of time on case management each month.  
Providers most frequently reported spending between thirty minutes and one hour on this task (31%), 
while only 11% reported spending less than 30 minutes on case management per month.  Clinical 
geneticists most frequently reported spending between thirty minutes and one hour on case 
management per month, compared to 20% of other providers.  Other providers most frequently 
reported spending more than four hours on this task per month (27%). 
 Providers most frequently reported spending between thirty minutes and one hour preparing 
for face-to-face visits each month.  Differences in the amount of time spent on this task were evident 
between clinical geneticists and other providers.   Forty-two percent of clinical geneticists reported 
spending this much time on face-to-face visits.  Other providers most frequently reported spending 
between one and two hours preparing for face-to-face visits (27%). 
 Providers were also asked how many hours they spent on other, non-specified administrative 
tasks per month.  Providers most frequently reported spending less than thirty minutes or more than 
four hours on these tasks.  Again, differences in the amount of time spent by clinical geneticists and 
other providers were evident.  Clinical geneticists most frequently reported spending less than thirty 
minutes on other administrative tasks each month (33%).  Providers were asked to describe these other 
administrative tasks.  Clinical geneticists descriptions included: documentation and dictation; developing 
care plans; writing emergency letters; communicating with clinic staff, primary care physicians, other 
health professionals, and non-parent family members; reviewing lab results; coordinating patient care 
with insurance companies and regional services; advocating for patients and connecting families with 
support groups; and working with the NBS program.  Comparatively, other providers most frequently 
reported spending more than four hours on these tasks each month (29%).  Tasks reported by other 
providers included: reviewing lab results and revising diet management plans; documentation; writing 
emergency letters and letters of medical necessity; communicating with primary care providers, clinical 
geneticists, and other health care professionals; coordinating patient care; educating families and 
gathering educational materials; compiling information for newsletters; procuring medical foods and 
formulas; and connecting families with area resources, including other families whose child(ren) 
has/have the same disorder. 
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Table 3a. Non-Visit Administrative Time
1
 
      Provider Type 







Time Spent on Phone with Family per month       
  Less than 30 minutes 29.03 (27) 34.62 (18) 21.95 (9) 
  30 minutes-1 hour 24.73 (23) 25.00 (13) 24.39 (10) 
  1-2 hours 21.51 (20) 23.08 (12) 19.51 (8) 
  2-4 hours 11.83 (11) 7.69 (4) 17.07 (7) 
  More than 4 hours 5.38 (5) 3.85 (2) 7.32 (3) 
  I don't do this 7.53 (7) 5.77 (3) 9.76 (4) 
  Not Reported - - - 
Time Spent Doing Case Management per month       
  Less than 30 minutes 10.75 (10) 7.69 (4) 14.63 (6) 
  30 minutes-1 hour 31.18 (29) 40.38 (21) 19.51 (8) 
  1-2 hours 19.35 (18) 25.00 (13) 12.20 (5) 
  2-4 hours 17.20 (16) 13.46 (7) 21.95 (9) 
  More than 4 hours 18.28 (17) 11.54 (6) 26.83 (11) 
  I don't do this 3.23 (3) 1.92 (1) 4.88 (2) 
  Not Reported - - - 
Time Spent Preparing for Face-to-Face Visits per month       
  Less than 30 minutes 15.05 (14) 17.31 (9) 12.20 (5) 
  30 minutes-1 hour 31.18 (29) 42.31 (22) 17.07 (7) 
  1-2 hours 22.58 (21) 19.23 (10) 26.83 (11) 
  2-4 hours 12.90 (12) 9.62 (5) 17.07 (7) 
  More than 4 hours 12.90 (12) 7.69 (4) 19.51 (8) 
  I don't do this 1.08 (1) 0.00 (0) 2.44 (1) 
  Not Reported 4.30 (4) 3.85 (2) 4.88 (2) 
Time Spent on Other Administrative Tasks per month       
  Less than 30 minutes 23.66 (22) 32.69 (17) 12.20 (5) 
  30 minutes-1 hour 17.20 (16) 15.38 (8) 19.51 (8) 
  1-2 hours 17.20 (16) 15.38 (8) 19.51 (8) 
  2-4 hours 13.98 (13) 15.38 (8) 12.20 (5) 
  More than 4 hours 21.51 (20) 15.38 (8) 29.27 (12) 
  I don't do this 1.08 (1) 1.92 (1) 0.00 (0) 
  Not Reported 5.38 (5) 3.85 (2) 7.32 (3) 
Do You Interact with insurance Companies       
  No 27.96 (26) 30.77 (16) 24.39 (10) 
  Yes 70.97 (66) 67.31 (35) 75.61 (31) 
  Not Reported 1.08 (1) 1.92 (1) 0.00 (0) 
1
Column percentages are shown. 
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 Providers were also asked whether they interacted with insurance companies.  As seen in Table 
3a, 71% of providers reported doing so.  Other providers more frequently reported interacting with 
insurance companies than did clinical geneticists.  Table 3b contains information on the amount of time 
that providers worked with insurance companies; this analysis includes only those providers who 
reported working with insurance companies.  Overall, providers most frequently reported spending less 
than thirty minutes or between one and two hours interacting with insurance companies.  Differences 
were evident by provider type.  Clinical geneticists most frequently reported spending less than thirty 
minutes working with insurance companies (26%), while other providers most frequently reported 
spending between one and two hours (29%) working with insurance companies. 
 
Table 3b. Amount of Time Spent Interacting with Insurance Companies per month
1
 








Less than 30 minutes 21.21 (14) 25.71 (9) 16.13 (5) 
30 minutes -1 hour 18.18 (12) 22.86 (8) 12.90 (4) 
1-2 hours 21.21 (14) 14.29 (5) 29.03 (9) 
2-4 hours 19.70 (13) 20.00 (7) 19.35 (6) 
More than 4 hours 16.67 (11) 14.29 (5) 19.35 (6) 
I don't do this 1.52 (1) 0.00 (0) 3.23 (1) 
Not Reported 1.52 (1) 2.86 (1) 0.00 (0) 
1
Column percentages are shown.  
 
 Providers were also asked to rank the three most time-intensive reasons that they interact with 
insurance companies.  Some providers rated more than one activity in the top three; all of these reports 
were taken into account in order to describe the variety of reasons why providers interact with 
insurance companies.  These reports are shown in Table 3c.  The most time-intensive reason providers 
reported working with insurance companies was for approvals for medical foods and formulas (64%); 
this was also the most time-intensive reason reported by both clinical geneticists and other providers.  
Approvals for medications was reported to be the second most time-intensive reason for working with 
insurance companies; forty-eight percent of all providers and sixty-two percent of clinical geneticists 
reported it was second most important.  General reimbursement for services was the most frequently 
reported third most time-intensive reason for interacting with insurance companies.  Thirty-six percent 
of all providers, twenty-seven percent of clinical geneticists, and fifty percent of other providers 
reported this as the third most time-intensive reasons they worked with insurance companies. 
 
Table 3c. Most Time-Intensive Reasons for Interacting with Insurance Companies among Providers who 
Interact with Insurance Companies
1
 
    First Second Third 
All Providers (n=66)       
  General Reimbursement for Services 9.72 (7) 6.78 (4) 36.07 (22) 
  Patient Eligibility for Care 8.33 (6) 16.95 (10) 21.31 (13) 
  Approvals for Medical Foods/Formulas 63.89 (46) 16.95 (10) 4.92 (3) 
  Approvals for Medications 16.67 (12) 47.46 (28) 6.56 (4) 
  Approvals for Durable Medical Equipment 0.00 (0) 8.47 (5) 16.39 (10) 
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  Approval for Hospital Services 0.00 (0) 1.69 (1) 8.20 (5) 
  Other 1.39 (1) 1.69 (1) 6.56 (4) 
Clinical Geneticists (n=35)       
  General Reimbursement for Services 11.90 (5) 5.88 (2) 27.03 (10) 
  Patient Eligibility for Care 7.14 (3) 11.76 (4) 21.62 (8) 
  Approvals for Medical Foods/Formulas 69.05 (29) 8.82 (3) 8.11 (3) 
  Approvals for Medications 11.90 (5) 61.76 (21) 2.70 (1) 
  Approvals for Durable Medical Equipment 0.00 (0) 5.88 (2) 21.62 (8) 
  Approval for Hospital Services 0.00 (0) 2.94 (1) 10.81 (4) 
  Other 0.00 (0) 2.94 (1) 8.11 (3) 
Other Providers (n=31)       
  General Reimbursement for Services 6.67 (2) 8.00 (2) 50.00 (12) 
  Patient Eligibility for Care 10.00 (3) 24.00 (6) 20.83 (5) 
  Approvals for Medical Foods/Formulas 56.67 (17) 28.00 (7) 0.00 (0) 
  Approvals for Medications 23.33 (7) 28.00 (7) 12.50 (3) 
  Approvals for Durable Medical Equipment 0.00 (0) 12.00 (3) 8.33 (2) 
  Approval for Hospital Services 0.00 (0) 0.00 (0) 4.17 (1) 
  Other 3.33 (1) 0.00 (0) 4.17 (1) 
1
Column percentages are shown. 
 
 Finally, dietitians were asked questions specifically about three-day diet recalls.  A total of 17 
dietitians completed these questions.  As shown in Table 3d, dietitians most frequently reported that 
51-60% of their patients and families provide a three-day diet recall (29%).  Dietitians most frequently 
reported spending between fifteen and thirty minutes (53%) preparing a three-day diet recall.  Finally, 
dietitians were asked what their protocol is when patients and families do not provide diet recall 
records.  The majority of dietitians (65%) reported that they complete the diet recall record with the 
families. 
 
Table 3d. Three Day Diet Recall Protocol among Dietitians 
    Total (n=17) 
Percent of Patients/Families Providing a 3-day Diet Recall   
  0-10% 5.88 (1) 
  11-20% - 
  21-30% 11.76 (2) 
  31-40% 5.88 (1) 
  41-50% 11.76 (2) 
  51-60% 29.41 (5) 
  61-70% 11.76 (2) 
  71-80% 17.65 (3) 
  81-90% 5.88 (1) 
  91-100% - 
Average Time Spent Preparing a 3-day Diet Recall   
  15-30 minutes 11.76 (2) 
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  30-45 minutes 52.94 (9) 
  45 minutes-1 hour 23.53 (4) 
  More than 1 hour 5.88 (1) 
  Not Reported 5.88 (1) 
Procedure When Patients/Families Do Not Provide Diet Recall (select all that apply)   
  Complete diet recall with them 64.71 (11) 
  Ask them to complete a diet recall during the visit and review it with them that day 11.76 (2) 
  Ask them to complete a diet recall at home and send it to the office for review and follow-up 11.76 (2) 
  Other 11.76 (2) 
 
 
4. Care Coordination and Models of Care Provision 
 
 Providers were asked to answer a number of questions regarding their responsibilities with 
patients and any models of care provision they used in practice.  These questions were asked of all 
providers; sample sizes vary throughout this section because of skip patterns. 
 First, providers were asked to rank their top three responsibilities when working with patients 
and their families.  Some providers rated more than one activity in the top three; all of these reports 
were taken into account in order to describe the variety of responsibilities providers have when working 
with patients.  These are shown in Table 4a.  Managing patients’ medical needs was the primary 
responsibility most frequently reported by providers (39%); educating patients and families was the 
most frequently reported secondary responsibility reported by providers (33%); communicating with 
primary care providers was the most frequently reported tertiary responsibility reported by providers 
(23%).  Reported responsibilities varied by provider type.  Clinical geneticists most frequently reported 
that they were responsible for managing medical needs (59%), managing dietary needs (37%), and 
educating patients and families (31%).  Other providers most frequently reported managing dietary 
needs (34%), educating patients and families (42%), and coordinating care for patients and families 
(26%).   
 
 
Table 4a. Primary Responsibilities of Providers when Working with Patients and Their Families
1
 
    First Second Third 
All Providers (n=87)       
  Coordinate Care for Patient and Family 13.33 (14) 7.37 (7) 17.89 (17) 
  Interact with Insurance Companies for Patients 0.95 (1) 2.11 (2) 7.37 (7) 
  Advocate for Patient Services 0.00 (0) 3.16 (3) 6.32 (6) 
  Manage Dietary Needs 20.00 (21) 24.21 (23) 5.26 (5) 
  Manage Medical Needs 39.05 (41) 11.58 (11) 3.16 (3) 
  Educate Patients and Families 16.19 (17) 32.63 (31) 18.95 (18) 
  Identify/Refer Patients to Community Resources, Support Groups, etc. 0.00 (0) 7.37 (7) 5.26 (5) 
  Communicate with Primary Care Providers 4.76 (5) 7.37 (7) 23.16 (22) 
  Communicate with Specialists, Hospital Staff, etc. 2.86 (3) 4.21 (4) 7.37 (7) 
  Other 2.86 (3) 0.00 (0) 5.26 (5) 
Clinical Geneticists (n=49)       
  Coordinate Care for Patient and Family 13.11 (8) 5.77 (3) 10.20 (5) 
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  Interact with Insurance Companies for Patients 0.00 (0) 1.92 (1) 2.04 (1) 
  Advocate for Patient Services 0.00 (0) 3.85 (2) 6.12 (3) 
  Manage Dietary Needs 9.84 (6) 36.54 (19) 10.20 (5) 
  Manage Medical Needs 59.02 (36) 13.46 (7) 2.04 (1) 
  Educate Patients and Families 14.75 (9) 25.00 (13) 30.61 (15) 
  Identify/Refer Patients to Community Resources, Support Groups, etc. 0.00 (0) 3.85 (2) 2.04 (1) 
  Communicate with Primary Care Providers 1.64 (1) 7.69 (4) 26.53 (13) 
  Communicate with Specialists, Hospital Staff, etc. 1.64 (1) 1.92 (1) 6.12 (3) 
  Other 0.00 (0) 0.00 (0) 4.08 (2) 
Other Providers (n=38)       
  Coordinate Care for Patient and Family 13.64 (6) 9.30 (4) 26.09 (12) 
  Interact with Insurance Companies for Patients 2.27 (1) 2.33 (1) 13.04 (6) 
  Advocate for Patient Services 0.00 (0) 2.33 (1) 6.52 (3) 
  Manage Dietary Needs 34.09 (15) 9.30 (4) 0.00 (0) 
  Manage Medical Needs 11.36 (5) 9.30 (4) 4.35 (2) 
  Educate Patients and Families 18.18 (8) 41.86 (18) 6.52 (3) 
  Identify/Refer Patients to Community Resources, Support Groups, etc. 0.00 (0) 11.63 (5) 8.70 (4) 
  Communicate with Primary Care Providers 9.09 (4) 6.98 (3) 19.57 (9) 
  Communicate with Specialists, Hospital Staff, etc. 4.55 (2) 6.98 (3) 8.70 (4) 
  Other 6.82 (3) 0.00 (0) 6.52 (3) 
1
Column percentages are shown. 
 
 Second, providers were asked about provision of care models used in their practices.  Providers 
were asked to rank from most to least important five models of care provision: using a team approach 
to care, practicing at satellite clinics, making visits to patient homes, using telemedicine technologies, 
and serving as a medical home.  Providers who reported that their practice used a particular model of 
care were then asked follow-up questions with regard to that model.  A total of eighty-six providers 
responded to questions regarding models of care. 
 Overall, ninety-nine percent of providers reported that their clinic used a team approach to 
caring for patients, forty-five percent reported that they practiced at satellite clinics, nineteen percent 
reported making home visits, twenty-six percent reported using telemedicine technologies, and sixty-
five percent reported serving as a medical home for patients.  The comparative importance of models of 
care is shown in Table 4b.  Using a team approach to care was rated as most important by ninety 
percent of providers.  Serving as a medical home and practicing at satellite clinics were most frequently 
ranked second and third most important models of care provision.  Utilizing telemedicine technologies 
was most frequently ranked fourth most important.  Additionally, thirty percent of providers reported 
that their clinic had a person who worked specifically as a care coordinator (data not shown). 
 














Using a Team Approach to Care 89.77 (79) 4.76 (3) 2.56 (1) 10.53 (2) 0.00 (0) 
Practicing at Satellite Clinics 4.55 (4) 30.16 (19) 25.64 (10) 15.79 (3) 33.33 (3) 
Making Visits to Patients' Homes 0.00 (0) 4.76 (3) 20.51 (8) 15.79 (3) 22.22 (2) 
Using Telemedicine Technologies 0.00 (0) 6.35 (4) 23.08 (9) 42.11 (8) 11.11 (1) 
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Serving as a Medical Home 5.68 (5) 53.97 (34) 28.21 (11) 15.79 (3) 33.33 (3) 
1
Column percentages are reported. 
 
 All eighty-five providers who reported that their practice utilized a team approach to care were 
asked to indicate who else participated in patient care teams, excluding themselves.  Provider responses 
are contained in Table 4c.  More than half of providers reported that teams were composed of clinical 
geneticists, dietitians/nutritionists, social workers, nurse, and genetic counselors.  Patient advocates, 
office/administrative managers, primary care providers, metabolic laboratory directors, and other 
providers were included less frequently.  ‘Other’ providers were specified by respondents and included 
nurse practitioners (n=6), medical assistants (n=1), psychologists (n=1), physician assistants (n=1), and 
biochemical genetics fellows (n=1). 
 
Table 4c. Team Membership (Excluding 
Respondent) Among Those Who Reported 




Clinical Geneticist 54.12 (46) 
Dietitian/Nutritionist 84.71 (72) 
Social Worker 51.76 (44) 
Nurse 64.71 (55) 
Patient Advocate 3.53 (3) 
Office/Administrative Manager 47.06 (40) 
Primary Care Providers 43.53 (37) 
Genetic Counselor 63.53 (54) 
(Metabolic) Laboratory Director 40.00 (34) 
Other 10.59 (9) 
 
 Given the importance that providers gave them in the survey, it is unsurprising that a number of 
comments in the Best Practices and Wrap-Up sections of the survey discussed the team approach.   Six 
providers mentioned the importance of the multidisciplinary team approach; three simply stated: 
 
“The multidisciplinary approach to care helps meet the complex needs of patients and families 
and divides the workload.” 
 
“Our team approach is very valuable to us.” 
 
“When the parents of children have easy access to the coordinator, dietician, social worker, 
clinic staff, and the physician, everything works much better.  This is especially important for 
children on special diets…” 
 
In fact, three others noted other team members (a social worker, dietitian, and administration/billing 
person) and two others discussed the need to expand the team.  One stated that the clinic has had 
difficulty utilizing the team approach because of the “lack of care providers interested in caring for 
[inborn errors of metabolism].”  Two providers pointed to the importance of other team members for 
easing clinical geneticists’ workload and as a way of addressing the shortage of clinical geneticists: 
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“A knowledgeable and dedicated metabolic dietician and nurse practitioner have greatly eased 
the load from our metabolic physicians.” 
 
“Metabolic/Genetic Nurse Practitioner/Dietitian partnerships work well for chronic 
management of most [inborn errors of metabolism] and should be cultivated given the increase 
[in] patient load and fewer biochemically trained physicians.” 
 
 Of the thirty-nine providers who reported that their practice utilized satellite clinics, only 
twenty-seven providers responded to follow-up questions regarding these clinics.  The reports of these 
twenty-seven providers are contained in Table 4d.  Providers reported working at a variety of satellite 
clinics; thirty-seven reported working at two clinics, while 30% reported working at three or more clinics.  
However, most providers (74%) reported only working at satellite clinics one to two days per month.  
Providers were also asked to identify the top three reasons they practice at satellite clinics.  Nearly all 
(96%) reported that satellite clinics were geographically easier for patients, while twenty-six percent 
reported that they practiced at satellite clinics because of uninsured patients. 
 
Table 4d. Characteristics of Satellite Clinic Practice Among Those Providing 
Care at these Places 
    Total (n=27) 
Number of Satellite Clinics Practiced At   
  One 33.33 (9) 
  Two 37.04 (10) 
  Three or More 29.63 (8) 
Number of Days Practicing at Satellite Clinics per Month   
  1-2 days 74.07 (20) 
  3-5 days 7.41 (2) 
  6-10 days 11.11 (3) 
  11-20 days - 
  More than 20 days 3.70 (1) 
  Not Reported 3.70 (1) 
Top Reasons for Practicing at Satellite Clinics   
  Geographically Easier for Patients 96.30 (26) 
  Satellite Clinic Specialization 11.11 (3) 
  Provider Convenience 7.41 (2) 
  Contractual Obligations 22.22 (6) 
  Financial Incentives of State Mandate 18.52 (5) 
  Uninsured Patients 25.93 (7) 
  Clinics Affiliate with my Employer (e.g., outreach facility) 22.22 (6) 
  Personal Beliefs 14.81 (4) 
  Other Patient Barriers 7.41 (2) 
  Other 3.70 (1) 
 
 Sixteen providers reported making visits to patients’ homes; however, only twelve providers 
answered follow-up questions regarding these visits.  Their responses are contained in Table 4e.  Most 
providers (67%) reported making home visits one to two days per month.  Providers were also asked the 
top three reasons they made home visits.  Half of providers reported that they made home visits 
because they were geographically easier for patients and because of other patient barriers.  Those other 
patients barrier included a lack of transportation (n=3), a “need to understand the environment” (n=1), 
and to “see why [families] can’t be compliant” (n=1).   
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Table 4e. Characteristics of Home Visit Practices Among Those Making Home 
Visits 
    Total (n=12) 
Number of Days Making Home Visits per Month   
  1-2 days 66.67 (8) 
  3-5 days 16.67 (2) 
  Not Reported 16.67 (2) 
Top Reasons for Making Home Visits   
  Geographically Easier for Patients 50.00 (6) 
  Provider Convenience - 
  Contractual Obligations - 
  Financial Incentives of State Mandate 8.33 (1) 
  Uninsured Patients - 
  Personal Beliefs 25.00 (3) 
  Other Patient Barriers 50.00 (6) 
  Other 16.67 (2) 
 
 All twenty-two providers who reported that their practice utilized telemedicine responded to 
follow-up questions regarding telemedicine.  Their responses are contained in Tables 4f and 4g.  As 
shown in Table 4f, eighty-two percent of providers utilize remote patient monitoring and fifty-nine 
percent report utilizing remote patient visits  Providers most frequently reported utilizing these types of 
telemedicine one to two days per month (44% and 46% respectively), as shown in Table 4g.  Thirty-six 
percent of providers reported using some other type of telemedicine.  Finally, half of providers who use 
telemedicine reported that it could be improved to assist in the care of metabolic patients.  Three 
providers mentioned difficulty accessing telemedicine and four reported that they needed the 
technology and equipment to be both better and simpler.  Providers also mentioned that families’ 
comfort with telemedicine was an issue (n=1) and that telemedicine needed to be better reimbursed 
(n=1).  Finally, two providers offered ideas of how they would like to use telemedicine technologies but 
currently cannot:  
 
"I respond to patient questions. Would be good to be more proactive in reaching them but there 
is insufficient time to do so." 
 















Table 4f. Characteristics of Telemedicine Practice among Those Who Use 
Telemedicine 
    Total (n=22) 
Remote Patient Monitoring   
  No 18.18 (4) 
  Yes 81.82 (18) 
Remote Patient Visits   
  No 40.91 (9) 
  Yes 59.09 (13) 
Other Types of Telemedicine   
  No 63.64 (14) 
  Yes 36.36 (8) 
Reasons for Using Telemedicine   
  Geographically Easier for Patients 81.82 (18) 
  Provider Convenience 54.55 (12) 
  Contractual Obligations 4.55 (1) 
  Financial Incentives of State Mandate - 
  Uninsured Patients - 
  Provider-to-Provider Communication about Patient 22.73 (5) 
  Personal Beliefs 9.09 (2) 
  Other Patient Barriers 9.09 (2) 
  Other 4.55 (1) 
Could Telemedicine Be Improved   
  No 31.82 (7) 
  Yes 50.00 (11) 
  Not Reported 18.18 (4) 
 







Patient Visits      
(n=13) 
1-2 days 44.44 (8) 46.15 (6) 
3-5 days 27.78 (5) 23.08 (3) 
6-10 days 11.11 (2) 7.69 (1) 
11-20 days 5.56 (1) 7.69 (1) 
More than 20 
days 5.56 (1) - 
Not Reported 5.56 (1) 15.38 (2) 
 
 Of the fifty-six providers who reported that their practice serves as a medical home, fifty-five 
providers responded to follow-up questions.  Sixty percent of providers stated that their practice served 
as the medical home for patients with metabolic conditions diagnosed following a positive newborn 
screening.  Of the twenty-two providers who stated that their practice did not serve as a medical home 
or were not sure if their practice served as a medical home, fifty-nine percent stated that one of the 
patients’ other providers served as the medical home.  Of those thirteen providers, twelve responded 
that the patients’ primary care providers served as the medical home; one provider declined to answer. 
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5. Challenges to Providing Care 
 
 Providers were asked to respond to a series of statements regarding challenges they face 
providing care to patients with metabolic conditions diagnosed following a positive NBS during the first 
year of life.  Statements reflected a variety of potential challenges, including geographic distance, clinic 
staffing, and educational needs and responsibilities.  Response categories ranged from ‘very challenging’ 
to ‘not at all challenging.’  A total of 84 providers responded to at least one statement; their responses 
are contained in Figure 5 (Appendix C, Table 5).  These analyses were not bifurcated by provider type. 
 Providers reported that factors associated with families were challenging.  More than half of 
respondents reported that parental/familial knowledge and awareness of the metabolic disorder (64%) 
and compliance with treatment and management protocols (55%), and language barriers (52%) between 
providers and patients/families were somewhat challenging.  Fifty-one percent of providers stated that 
the geographic distance between providers and families was somewhat challenging; an additional 43% 
stated that distance was very challenging.  Three comments were made reflecting this challenge: 
 
“Our clinic services the entire state so we face challenges in actually getting families to clinic.  
Some of our patients drive from 3 or more hours away to be seen and when a condition calls for 
that perhaps more than every couple of months.” 
 
“The size of the catchment area and ability to get the services to families far away.” 
 
“Solo practice with too large a geographic area to know all the community resources as well as 
needed for optimal care.” 
 
 Factors associated with the health care system were also considered challenging.  Fifty-two 
percent of providers reported that having to take on multiple roles when providing care was somewhat 
challenging; an additional thirteen percent of providers reported it was very challenging.  Primary care 
providers knowledge of metabolic disorders was also reported as challenging – twenty-five percent of 
providers reported it was very challenging and forty-eight percent of providers reported it was 
somewhat challenging.  One provider commented that, “our attempts to educate [primary care 
providers] have also met with resistance.”  Additionally, providers frequently reported that having 
enough time to provide patients/families with all necessary resources was very (41%) or somewhat 
(44%) challenging.  Forty-six percent of providers rated the ability to transition patients to hospital 
providers when necessary as not very challenging.   
 Providers reported that the most challenging aspect of their work was the lack of 
reimbursement for all of the care that patients and families need.  Sixty-two percent of providers 
reported that reimbursement was very challenging.  An additional 27% rated reimbursement as 
somewhat challenging.  That providers’ find reimbursement challenging was reflected in their comments 
at the end of the survey; ten providers specifically mentioned reimbursement.  One provider summed 
the problem with reimbursement succinctly: “Very poor reimbursements for the clinic visits.  No 
reimbursement for all the time spent on patient care outside of clinic.  We lose money on every patient 
we see.  We are dependent on philanthropy and the small amount the State provides to survive.” 
Two other providers actually reported that reimbursement was not an issue because they were state 
employees; one stated, “I am fortunate to work in a state with a coordinated program -- we work closely 
with the NBS program and have funding to support [a registered dietitian, social worker], and other staff 
to provide comprehensive care.”  
 Fifty-four percent of providers reported the adequacy of clinic staffing was very or somewhat 
challenging.  Nine providers specifically mentioned staff adequacy as an issue they faced; three 
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mentioned general staffing issues, while three mentioned the specific lack of a physician, a social work, 
and a staff member in charge of billing/referral, respectively.  Three providers mentioned the need for 
clinical geneticists trained in metabolic conditions: 
 
“The greatest challenge is the number of patients and the relative lack of enough qualified 
physicians who are able to provide knowledgeable care. We need more geneticists trained in 
metabolic diseases.” 
 
“Clinical Geneticists [are] untrained in metabolism or nutrition.” 
 
“Knowledgeable faculty to diagnose and treat rare disorders. Maybe the federal government 
needs to offer funding for metabolic specialists. How about mandating a metabolic specialist for 
every state?” 
 
 Unique insurance protocols and the availability of prescription medications and medical foods 
were related challenges.  Seventy-seven percent of providers reported that insurance protocols were 
somewhat or very challenging.  Eight providers mentioned general insurance issues in their comments.  
Providers stated: 
 
“Largest amount of time is spent chasing insurance issues around and that is the one area where 
we have no support so providers and limited office staff end up spending their time doing it.” 
 
“Insurance issues are overwhelming at times.” 
 
“We are all feeling overworked and underappreciated.  We seem to always have to battle for 
our patients and their care needs as we deal in rare disorders and insurers, etc. have not heard 
of most of them.” 
 
 Eighty-seven percent of providers reported that the availability of prescription medications 
and/or medical foods was somewhat or very challenging.  Fourteen providers commented that working 
with insurers for medical foods and formulas was difficult: 
 
“The paperwork alone required for the medications/formulas/foods is quite time consuming.” 
 
“Making insurers aware of the needs of metabolic [patients] specifically the need to cover 
medications and medical foods.”  
 
“Fighting with insurance companies to cover for medical nutrition products.” 
 
“Too much insurance resistance to cover formula, meds, food, testing, etc.” 
 
“Refusal of coverage by health plan providers for medical foods, modified low protein foods, 
medications used to treat IEM.” 
 




Not only is dealing with insurance companies to cover medical foods and formulas time consuming, but 
patients’ quality of care and health is at stake if providers are unable to demonstrate the importance of 
such treatments to insurance companies.    
 The interconnectedness of the issues discussed above – the time spent with patients, 
compliance, staffing adequacy, and reimbursement – are reflected in two provider comments.  These 
providers stated: 
 
“The greatest challenge is donating the necessary time to the patients.  Ongoing communication 
and a strong bond between doctor and patient/parent is the key to successful treatment, and 
metabolic geneticists are in short supply but high demand.” 
 
“Since care for these disorders is not well reimbursed, we are not well staffed.  Staffing and time 
are constant problems.” 
 
 Thirty-eight percent rated their own educational needs regarding metabolic disorders as not 
very challenging, despite the fact that thirty-four percent of providers reported needing periodic and 
twenty-seven percent reported appreciating frequent updates about metabolic disorders and care 
practices.  One reason why providers own educational needs may not be a substantially challenging 
issue can be traced to the comments providers included in the survey.  Four separate providers stated 
that they have found sharing ideas with other providers and clinics was valuable.  Three of these 
providers specifically cited electronic methods of communication; two stated:  
 
“ListServes among metabolic providers has been VERY helpful for sharing information and case 
reports.” 
 
“ListServes have been very VALUABLE as a way to communicate with other metabolic 
providers.” 
 
 Forty-two percent of providers reported that their communication with state NBS or follow-up 
programs was not at all challenging.  One provider stated that “a close partnership between the 
newborn screening program and the metabolic clinicians helps facilitate rapid interpretation of results 
and proper emergent management when necessary.”  One of the four providers who was experiencing 
difficulty working with NBS systems reported that “the lack of communication from the state NBS lab to 
our in-house NBS coordinator to the MD/RD involved in the care of metabolic patients has greatly 
increased over the last year [has resulted in a] delay in working with positive cases.” 
 One other challenge was mentioned in provider comments that was not included in the survey.  
Four providers mentioned the lack of knowledge of the history of the disorder and lack of guidelines for 
care.  Two providers stated:  
 
“A consensus on one way to treat the particular disorder. Every center treats patients 
differently.” 
 
“Lack of knowledge about the prognosis and best treatments as well as the natural history of 
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 Providers were asked to share information on the educational practices and resources they use 
when working with families.  A total of 86 providers answered at least one question in the education 
section of the survey.  These analyses were not examined by provider type.   
 First, providers were asked to indicate the three things about which they educate families.  Two 
topics were reported by nearly all providers: treatment and management for the disorders (95%) and 
basic information about the disorder (90%).  Approximately half of providers also reported educating 
families about the complications (50%) and prognosis (48%) of the disorder.   
 Next providers were asked about the average amount of time per month that they spend 
educating families of children with metabolic disorders from birth to age one.  Providers most frequently 
reported spending between one and two hours each month (31%) educating families.  Approximately 
38% of providers reported spending between three and ten hours educating families each month.  
Seven percent of providers reported spending more than twenty hours each month educating families. 
 Providers were also asked to indicate the three educational materials they use most frequently 
with families.  The majority of providers reported using pamphlets and resource binders (87%), websites 
(86%), and support groups (67%) to educate families.  Fewer providers reported educating families with 
parent advocates (13%) and other materials (12%). 
 In their comments, two providers reported needing additional educational materials.  One 
reported the need for easy to read educational materials for families; another discussed the need for 
educational materials explaining the difference between true and false positives, and borderline results.  
Three providers indicated that they needed more time to educate families on metabolic disorders; these 
providers stated: 
 
“…time to educate our lower literacy families on the disorders.” 
 
“Because we have a regional program and a very small team, we don't see the children often 
and I think this impairs our ability to teach the families important aspects of the disorders.” 
 
“Having the time to educate the families and primary care providers about the metabolic 
disorder and their role in management. “ 
 
 Providers also reported that the most common resources of information that families used were 
websites (100%) and pamphlets (58%).  Previous experience with metabolic disorders (35%) and contact 
with follow-up coordinators (29%) and primary care providers (22%) were also frequently cited sources 
of education used by families.  Given the sources of education used by families, providers reported that 
the information families have about metabolic disorders when they visit the providers’ practice is only 
accurate sometimes (69%).   
 
Table 6. Educational Practices and Resources Used by Providers 
    
Total 
(n=86) 
Things Providers Educate Families About   
  Basic Information About the Disorder 89.53 (77) 
  Treatment/Management for the Disorder 95.35 (82) 
  Complications of the Disorder 50.00 (43) 
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  Prognosis of the Disorder 47.67 (41) 
  Other Services that the Patient May Need 16.28 (14) 
  Insurance Protocols Pertaining to the Disorder 6.98 (6) 
  Other 2.33 (2) 
Number of Hours Spent Educating Families per month   
  Less than 1 hour 10.47 (9) 
  1-2 hours 31.40 (27) 
  3-5 hours 19.77 (17) 
  6-10 hours 18.60 (16) 
  11-20 hours 12.79 (11) 
  More than 20 hours 6.98 (6) 
Educational Materials Providers Use Most Frequently (select three)   
  Pamphlets/Resource Binders 87.21 (75) 
  Parent Advocates 12.79 (11) 
  Support Groups 67.44 (58) 
  Websites 86.05 (74) 
  Other 11.63 (10) 
Most common Sources of Information Used by Families (select three)   
  Websites 100.00 (86) 
  Previous Experience with Disorder 34.88 (30) 
  Pamphlets 58.14 (50) 
  NBS Follow-up Coordinator 29.07 (25) 
  Primary Care Providers 22.09 (19) 
  Other 12.79 (11) 
How Often Information Families have about Disorders are Accurate 
  Always 0.00 (0) 
  Often 9.30 (8) 
  Sometimes 68.60 (59) 
  Rarely 18.60 (16) 
  Never 0.00 (0) 
  Not Applicable 2.33 (2) 
  Not Reported 1.16 (1) 
 
7. Relationships with Primary Care Providers 
 
 Providers were asked about the relationships between primary care providers and metabolic 
professionals.  A total of 84 metabolic providers answered questions regarding their relationships with 
primary care providers; those results are presented here.  Only one primary care provider was eligible 
for the final sample of providers used in this analysis; therefore, those results are not presented. 
 Seventy-six percent of metabolic providers reported working with primary care providers; 
nineteen percent reported that they did not work with primary care providers (data not shown).  All 
metabolic providers – whether or not they worked with primary care providers – were eligible to answer 
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questions about their perceptions of primary care providers’ knowledge and communication with 
primary care providers.   
 Metabolic providers were asked to rate their level of agreement from ‘strongly agree’ to 
‘strongly disagree’ on four general perceptions about primary care providers.  These are shown in Figure 
7a (Appendix C, Table 7a).  The majority of metabolic providers agreed or strongly agreed that providers 
often lack knowledge about metabolic disorders on the NBS panel (94%).  Despite this, most providers 
also agreed or strongly agreed that primary care providers should participate on metabolic care teams 
(73%) and act as the medical home for patients (64%).  However, only thirty-two percent of providers 
agreed or strongly agreed that primary care providers should act as a liaison to the insurance company 
for patients with metabolic disorders.   
 Metabolic providers were also asked to rate their level of agreement from ‘strongly agree’ to 
‘strongly disagree’ on three measures of communication with primary care providers.  Eighty-two 
percent of metabolic providers agreed or strongly agreed that communicating with primary care 
providers was a priority, including forty-eight percent who reported they strongly agreed.  Eighty 
percent of metabolic providers agreed or strongly agreed that communication with primary care 
providers provides easy to use, factual information about the patients’ health.  Sixty percent agreed or 
strongly agreed that communication occurs both from metabolic providers to primary care providers 
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Figure 7a. Metabolic Perceptions of Primary Care Providers 
Participation in Patient Care (n=84)
Strongly Agree Agree Somewhat Neither Agree nor Disagree Disagree Somewhat
Strongly Disagree Don't Know/ Not Applicable Not Reported
 35
 Metabolic providers were also asked to rate the effectiveness of methods that facilitate the 
sharing of patient management with primary care providers from ‘very effective’ to ‘not effective at all.’  
These results are shown in Figure 7b (Appendix C, Table 7b).  Metabolic providers most frequently 
reported written emergency care plans (77%) and consultation letters from specialists (63%) as very 
effective.  Condition-specific fact sheets (88%) and shared or interoperable electronic health records 
(81%) were rated very to somewhat effective.  Metabolic providers rated active care plans (48%), 
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 Finally, providers were asked to rank the top three ways they communicated with primary care 
providers after a patient’s routine visit.  Some providers rated more than one activity in the top three; 
all of these reports were taken into account in order to describe the variety of methods providers use to 
communicate with primary care providers.  These responses are contained in Table 7c.  The most 
common primary ways of communicating with primary care providers were phone call (41%) and fax 
(35%).   
 




  First Second Third 
Email 3.37 (3) 24.32 (18) 32.81 (21) 
Fax 34.83 (31) 20.27 (15) 23.44 (15) 
Phone Call 40.45 (36) 31.08 (23) 20.31 (13) 
Postal Mail 17.98 (16) 21.62 (16) 23.44 (15) 
Other 3.37 (3) 2.70 (2) 0.00 (0) 
1
Column percentages are shown. 
 
 
8. Attitudes About Expanding the Newborn Screening Panel 
 
 In an effort to learn about providers attitudes about expanding the NBS panel, providers were 
asked to rate their level of agreement with a series of statements about the impact of expanding the 
panel from ‘strongly agree’ to ‘strongly disagree.’  A total of 83 providers had valid responses to at least 
one of these statements and were included in these analyses.  Analyses are contained in Figure 8 
(Appendix C, Table 8). 
 Providers most frequently strongly agreed that there are not currently enough providers 
educated to care for patients with metabolic disorders on an expanded NBS panel (63%).  Additionally, 
metabolic providers strongly agreed that expanding the NBS panel would increase their case load (60%) 
and the amount of time spent treating patients (54%).  Finally, approximately 40% of providers strongly 
agreed that they were concerned about being reimbursed for care they would need to provide to new 
patients (41%), and that there would not be evidence-based treatment protocols for the new conditions 
(41%).  Sixty-four percent of providers were also concerned that an expanded NBS panel would result in 
more false-positive disorders being detected.  Five providers reported specific concerns about 
expanding the NBS panel due to a lack of treatment protocols and advanced testing.  They stated: 
 
“There ought to be nationalization of standards of NBS as well as the creation of a budget to 
support the effort. The model to follow might be the national highway system.” 
 
“Having treatment guidelines, when they are available, is helpful but I understand that there 
isn't always enough evidence to develop a definitive protocol.” 
 
“This will all become very ugly and people will have even less trust in the medical establishment.  
Adding Comparative Genomic Hybridization will be a disaster.  We need more research on what 
these variants of unclear significance mean.” 
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“A lack of evidence-based treatment strategies.  This is also my biggest concern with regards to 
expanding the number of disorders on the screening panel.  I am not in favor of identifying 
disorders for which there is no effective therapy.” 
 
“Lack of knowledge on the significance, natural history and treatment of many of the expanded 
disorders, “ 
 
 Despite these concerns, seventy-five percent of providers were excited about treating children 
with metabolic disorders who would otherwise not have received treatment.  Providers also did not 
report being concerned that an expanded would make working with parents more difficult; forty-seven 
percent disagreed or strongly disagreed with the statement and an additional thirty percent reported 
that they neither agreed nor disagreed. 
 One statement garnered reports that were relatively spread.  In response to the statement “I 
may refer patients diagnosed with metabolic disorders added to the NBS panel to specialists in those 
disorders”, thirty percent of providers agreed or strongly agreed, thirty-five percent disagreed or 





0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
I am concerned that adding disorders to the NBS panel would result in a
greater number of false-positives
I am excited to think about being able to treat children with metabolic
diseases that would otherwise have not been detected at birth
Adding disorders to the NBS panel will make working with parents much
more difficult
I am concerned that there would not be evidence-based treatment
protocols to care for children diagnosed with disorders added to the NBS
panel
There are not currently enough practitioners educated to care for patients
diagnosed with metabolic disorders on an expanded NBS panel
I am concerned about being reimbursed for all of the care that I would
provide to patients diagnosed with a disorder on an expanded NBS panel
I may refer patients diagnosed with metabolic disorders added to the NBS
panel to specialists in those disorders.
Expanding the number of metabolic conditions on the NBS panel would
increase the time I spend treating patients.
Increasing the number of metabolic disorders on the NBS panel in my
state would increase my caseload
Figure 8. Attitudes Toward Expanding the NBS Panel (n=83)
Strongly Agree Somewhat Agree Neither Agree nor Disagree Somewhat Disagree
Strongly Disagree Don't Know/ Not Applicable Not Reported
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Next Steps and limitations: 
 
This survey was conducted on a broad spectrum of providers who treat patients with metabolic 
disorders, but it is not generalizable to all metabolic providers due to selective response.  Nonetheless, 
the responses here mirror strongly those found in the first phase interview pilot project.   
 
Two themes emerge here.  One is that the extra-care process post NBS, specifically care coordination 
and education, needs to be investigated for effectiveness and best practices.  Care management and 
payment management need to be the core functions of at least one team member.  The field also needs 
to find more consistent and effective ways of educating families and primary care providers.   
 
Secondly is that workforce issues need to be addressed.  The current consensus is that resources are 
inadequate to handle the intensity of care volume as it currently exists.  Expansions to the metabolic 
NBS panel without first addressing the ineffectiveness of the current models of care will only exacerbate 
these issues.  Explored should be reconfigurations to the care teams, better care protocols, and 
standard methods of communication across the spectrum of care.  The use of technology and 
























A National Assessment of the Newborn Screening Workforce 
 
Informed Consent Information 
You have been invited to participate in a research project that will examine the process of care for patients diagnosed with 
metabolic conditions that are detected on newborn screen (NBS) from diagnosis to the first birthday. While you will not 
receive any direct benefits from your participation, the information gathered here will be valuable for informing the current 
and ongoing policy discussions regarding reimbursement for genetic services. 
 
This project is being conducted by Robert J. McGrath, Associate Professor in the Department of Health Management and 
Policy at the University of New Hampshire (UNH). This project is funded by the National Coordinating Center for the Regional 
Genetic and Newborn Screening Service Collaboratives (NCC). This survey asks you questions regarding the process of care 
and challenges to providing care for average patients with metabolic conditions. You will not be asked to describe any specific 
cases.  You will also be asked about how you believe an expanded NBS panel will impact your work.  
 
Your participation is voluntary, and you may withdraw your consent and discontinue participation at any time. Although we 
hope that you will answer every question, you are certainly free to skip any questions. Your responses will be kept 
confidential. The survey data will only be analyzed and reported in aggregated ways that will not reveal your identity. Thus, no 
individual identity will be determinable through demographic variables such as zip code. The results may be used in reports, 
publications, and/or presentations.  
 
This project will be successful only if you help us. We know that you are extremely busy, but please take 20 minutes to 
complete the confidential survey. Because of the highly specialized field of caregivers we are interviewing, you are one of 
approximately 200 health care providers who will be asked to participate in this research. Participation in this study is 
expected to present minimal risk to you. 
 
If at any time you have questions or concerns about any procedure in this project, you may e-mail the investigator 
(Robert.McGrath@unh.edu) or speak with the investigator by calling 603-862-5047. You should also understand that you will 
be able to request a summary of the findings. If you have questions about your rights as a research subject, you may contact 
Julie Simpson in UNH Research Integrity Services, by phone 603-862-2003 or email julie.simpson@unh.edu.  
 
Instructions 
Thank you for participating in this survey of genetic service providers who treat children with metabolic disorders. This survey 
is being conducted by Robert J. McGrath, Associate Professor of Health Management and Policy at the University of New 
Hampshire, and is funded by the National Coordinating Center for the Regional Genetic and Newborn Screening Service 
Collaboratives.  
 
This survey seeks to understand the scope and intensity of services provided to patients with metabolic disorders and their 
families by all caregivers from the time of positive newborn screen (NBS) and subsequent diagnosis of a metabolic disorder, 
through the first year of life. 
 
We take a broad view of both the care provided, including time spent with the patient and time spent working on the 
patient’s behalf, and the responsibilities of people providing care, including the work of clinical providers and office staff. We 
are also interested in your views on the potential consequences of adding tests to your state’s current NBS panel. Your input is 
highly valuable in informing current policy discussions nationally. 
 
Thank you for your time and participation. 
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1. What is your primary professional role? 
 
 Clinical Geneticist   Patient Advocate [SKIP TO Section 2, Page 8, question 36] 
 Dietitian/Nutritionist  Office/Administrative Manager [SKIP TO Part II, Page 6, question 25]  
 Social Worker   Genetic Counselor 
 Nurse     Primary Care Provider 
 Other (specify) ___________________________________________________________ 
 
2. Approximately what percentage of your practice/work is dedicated to treating children who have been 
identified through NBS and subsequently confirmed to have a metabolic disorder? 
 0-10%     51-60% 
 11-20%     61-70% 
 21-30%     71-80% 
 31-40%     81-90% 
 41-50%     91-100% 
 
 
 Section 1: Process of Care   
 
In order to assess the scope and intensity of services that you provide to patients with metabolic disorders, we 
distinguish among 3 categories of metabolic disorders: organic acid disorders, fatty acid oxidation disorders, 
and amino acid disorders. We recognize that there is substantial variation within each category of disorder; 
however, please answer the following questions with regards to an average patient in your practice diagnosed 
with each type of reference metabolic disorder after a positive NBS from birth through the first year of life.  
 
Also, for all questions, please describe only YOUR workload and not the workload of other professionals with 
whom you may work. 
 
While we recognize that not every state tests for all of the disorders on the Uniform NBS panel, we ask only 
about the disorders on the panel in order to gain a broad understanding of processes of care across the United 
States. 
 
 Part I. Processes of Care by Metabolic Disorder Type 
 
3. Do you treat children diagnosed with the following categories of metabolic disorders?   
Please check all that apply. 
  Organic Acid Disorders (for example, Propionic Academia)             [IF CHECKED - ANSWER PART 1A, pg. 3] 
  
Fatty Acid Oxidation Disorders (for example, Carnitine Uptake Defect / 
Carnitine Transport Defect)               
[IF CHECKED - ANSWER PART 1B, pg. 4] 
  Amino Acid Disorders (for example, Classic Phenylketonuria)           [IF CHECKED - ANSWER PART 1C, pg. 5] 





 Part IA. Processes of Care for Organic Acid Disorders 
 
For the following questions, please think of an average patient in your practice who has been diagnosed with a disorder of 
organic academia from the time of positive screen through the first year of life. 
 
4. Please indicate up to 3 disorders of organic academia that you see most often in your practice. 
 Propionic Academia (PROP) 
 Methylmalonic Acidemia (Methylmalonyl-CoA Mutase) (MUT) 
 Methylmalonic Acidemia (Cobalamin Disorders) (Cbl, A, B) 
 Isovaleric Acidemia (IVA) 
 3-Methylcrotonyl-CoA Carboxylase Deficiency (3-MCC) 
 3-Hydroxy-3-Methyglutaric Aciduria (HMG) 
 Holocarboxylase Synthase Deficiency (MCD) 
 B-Ketothiolase Deficiency (BKT) 
 Glutaric Acidemia Type I (GA1) 
 Not Applicable 
 
5. How soon after the NBS lab detects an abnormal blood result do you typically talk to a patient’s family on 
the phone for the first time? 
    The Same or Next Day   Within the Month 
  Within the Week    Within Six Months 
  Within Two Weeks    Later than Six Months 
 
6. Approximately how long is your first phone call with the patient’s family? 
    Less than 1 Hour    4-6 Hours 
  1-2 Hours     More than 6 Hours 
  2-4 Hours    
 
7. How soon after the NBS lab detects an abnormal blood result do you typically see a patient and their 
family for the first time? 
    The Same or Next Day   Within the Month 
  Within the Week    Within Six Months 
  Within Two Weeks    Later than Six Months 
 
8. Approximately how long is your first visit with a patient and their family?   
    Less than 1 Hour    4-6 Hours 
  1-2 Hours     More than 6 Hours 
  2-4 Hours    
 
9. How frequently do you see a patient and their family for follow-up after the first visit during the… 
 More than Once a 
Week 
 Once a Week  2-3 Times 
per Month 
 Once a 
Month 
 Every Couple 
of Months 
 Never 
First Month            
Months 2-3            
Months 4-6            
Months 7-12            
 
10. On average, how long are follow-up visits with you during the first year of life? 
    Less than 15 Minutes   45 Minutes-1 Hour 
  15-30 Minutes    More than 1 Hour 
  30-45 Minutes    
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 Part IB. Processes of Care for Fatty Acid Oxidation Disorders 
 
For the following questions, please think of an average patient in your practice who has been diagnosed with a disorder of 
fatty acid oxidation from the time of positive screen through the first year of life. 
 
11. Please indicate up to 3 disorders of fatty acid oxidation that you see most often in your practice. 
  Carnitine Uptake Defect/Carnitine Transport Defect (CUD) 
  Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD) 
  Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD) 
  Long-Chain L-3 Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD) 
  Trifunctional Protein Deficiency (TFP) 
 
12. How soon after the NBS lab detects an abnormal blood result do you typically talk to a patient’s family 
on the phone for the first time? 
    The Same or Next Day   Within the Month 
  Within the Week    Within Six Months 
  Within Two Weeks    Later than Six Months 
 
13. Approximately how long is your first phone call with the patient’s family? 
    Less than 1 Hour    4-6 Hours 
  1-2 Hours     More than 6 Hours 
  2-4 Hours    
 
14. How soon after the NBS lab detects an abnormal blood result do you typically see a patient and their 
family for the first time? 
    The Same or Next Day   Within the Month 
  Within the Week    Within Six Months 
  Within Two Weeks    Later than Six Months 
 
15. Approximately how long is your first visit with a patient and their family? 
    Less than 1 Hour    4-6 Hours 
  1-2 Hours     More than 6 Hours 
  2-4 Hours    
 
16. How frequently do you see a patient and their family for follow-up after the first visit during the… 
 More than 
Once a 
Week 
 Once a 
Week 
 2-3 Time 
per Month 






First Month            
Months 2-3            
Months 4-6            
Months 7-12            
 
17. On average, how long are follow-up visits with you during the first year of life? 
    Less than 15 Minutes   45 Minutes-1 Hour 
  15-30 Minutes    More than 1 Hour 




 Part IC. Processes of Care for Amino Acid Disorders 
 
For the following questions, please think of an average patient in your practice who has been diagnosed with a disorder of 
amino acid metabolism from the time of positive screen through the first year of life. 
 
18. Please indicate up to 3 disorders of amino acid metabolism that you see most often in your practice. 
  Argininosuccinic Aciduria (ASA) 
  Citrullinemia, Type I (CIT) 
  Maple Syrup Urine Disease (MSUD) 
  Homocystinuria (HCY) 
  Classic Phenylketonuria (PKU) 
  Tyrosinemia, Type I (TYR I) 
 
19. How soon after the NBS lab detects an abnormal blood result do you typically talk to a patient’s family 
on the phone for the first time? 
    The Same or Next Day   Within the Month 
  Within the Week    Within Six Months 
  Within Two Weeks    Later than Six Months 
 
20. Approximately how long is your first phone call with the patient’s family? 
    Less than 1 Hour    4-6 Hours 
  1-2 Hours     More than 6 Hours 
  2-4 Hours    
 
21. How soon after the NBS lab detects an abnormal blood result do you typically see a patient and their 
family for the first time? 
    The Same or Next Day   Within the Month 
  Within the Week    Within Six Months 
  Within Two Weeks    Later than Six Months 
 
22. Approximately how long is your first visit with a patient and their family?   
    Less than 1 Hour    4-6 Hours 
  1-2 Hours     More than 6 Hours 
  2-4 Hours    
 
23. How frequently do you see a patient and their family for follow-up after the first visit during the… 
 More than 
Once a 
Week 
 Once a 
Week 
 2-3 Time 
per Month 






First Month            
Months 1-3            
Months 3-6            
Months 6-12            
 
24. On average, how long are follow-up visits with you during the first year of life? 
    Less than 15 Minutes   45 Minutes-1 Hour 
  15-30 Minutes    More than 1 Hour 
  30-45 Minutes    
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 Part II. Non-Visit Administrative Time 
 
For each of the following tasks, please estimate the amount of time you personally spend performing each of these non-visit 
activities per month during an average patient’s first year of life. These questions do NOT distinguish between disorders of 
organic acid, fatty acid oxidation, or amino acid. 
 
Thinking about an average patient in your practice diagnosed with a metabolic disorder detected on NBS from the time of 
positive screen through the first year of life... 
 
 - Dieticians ONLY – ALL others go to page 7 
25. What percentage of your patients and their families, when asked, provide a 3-day diet recall record? 
 0-10%     51-60% 
 11-20%     61-70% 
 21-30%     71-80% 
 31-40%     81-90% 
 41-50%     91-100% 
 
26. On average, how long do you spend preparing a 3-day diet recall?  
    Less than 15 Minutes   45 Minutes-1 Hour 
  15-30 Minutes    More than 1 Hour 
  30-45 Minutes    
  
27. What do you do when patients and their families do not provide diet recall records? Please select all 
that apply. 
  Complete Diet Recall with Them 
  Ask Them to Complete a Diet Recall during the Visit and Review it with Them That Day 
  Ask them to Complete a Diet Recall At Home and Send it to the Office for Review and Follow-up 




 - ALL Providers and Administrative/Office Staff -   
 
28. About how long do you spend talking on the phone with the family per month? 
    Less than 30 Minutes   2-4 Hours 
  30 Minutes-1 hour    More than 4 Hours 
  1-2 Hours     I don’t do this 
 
29. About how long do you spend doing case management per month?   
    Less than 30 Minutes   2-4 Hours 
  30 Minutes-1 hour    More than 4 Hours 
  1-2 Hours     I don’t do this 
 
30. Do you spend time interacting with insurance companies about patients with metabolic disorders? 
  No [SKIP TO question 33]     Yes 
 
31. About how long do you spend interacting with insurance companies per month? 
    Less than 30 Minutes   2-4 Hours 
  30 Minutes-1 hour    More than 4 Hours 
  1-2 Hours     I don’t do this 
 
32. Please rank the 3 most time-intensive reasons you interact with insurance companies?  
 First  Second  Third 
General Reimbursements for Services      
Patient Eligibility for Care      
Approvals for Medical Foods/Formulas      
Approvals for Medications      
Approvals for Durable Medical Equipment      
Approval for Hospital Services      
Other ______________________      
 
33. About how long do you spend preparing for face-to-face visits per month? Please include time that you 
spend meeting with medical staff, learning about the disorder, reviewing medical records, etc. but do not 
take into account time that you spend doing administrative tasks or working with insurance companies. 
    Less than 30 Minutes   2-4 Hours 
  30 Minutes-1 hour    More than 4 Hours 
  1-2 Hours     I don’t do this 
 
34. About how long do you spend doing other administrative tasks not already considered per month? 
    Less than 30 Minutes   2-4 Hours 
  30 Minutes-1 hour    More than 4 Hours 
  1-2 Hours     I don’t do this [SKIP TO SECTION 2, Next Page] 
 







 Section 2: Care Coordination 
 
 Part I. General 
 
Thinking about an average patient in your practice diagnosed with a metabolic disorder detected on NBS from 
the time of positive screen through the first year of life… 
 
36. What are your primary responsibilities when working with patients and their families?  Please 
rank your top 3 responsibilities. 
 First  Second  Third 
Coordinate Care for Patient and Family      
Interact with Insurance Companies for Patients      
Advocate for Patient Services      
Manage Dietary Needs      
Manage Medical Needs      
Educate Patients and Families      
Identify and/or Refer Patients to Community 
Resources, Support Groups, etc. 
     
Communicate with Primary Care Providers      
Communicate with Specialists, Hospital Staff, etc.      
Other _______________________________      
 
37. Is there someone at your clinic who works specifically as a care coordinator? 
  No      Yes 
 
38. Practices/clinics use different models to meet the needs of their patients and their patients’ families. 
Please rank the following practice models in the order of their importance to you in caring for patients with 
metabolic disorders and their families. 
 
 Most 
Important                        
 2nd Most 
Important
 3rd Most 
Important 









Using a Team Approach to Care            SKIP TO Part II, pg. 9 
Practicing at Satellite Clinics            SKIP TO Part III, pg. 9 
Making Visits to Patients’ Homes             SKIP TO Part IV, pg. 9 
Using Telemedicine Technologies            SKIP TO Part V, pg. 10 
Serving as a Medical Home            SKIP TO Part VI, pg. 11 
 
  
For each practice model that you or your practice use,  
Please respond to EACH of the corresponding sections on that model. 
If you use MORE than ONE Model, please answer question 53 in addition to each section. 
If you do not use ANY please skip to Part VII (question 57, page 12). 
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Thinking about an average patient in your practice diagnosed with a metabolic disorder detected on NBS from 
the time of positive screen through the first year of life… 
 
 Part II. Team Approach to Care 
 
39. Excluding yourself, who else is part of the care team for patients diagnosed with metabolic disorders? 
Please check all that apply 
    Clinical Geneticist    Office/Administrative Manager 
  Dietitian/Nutritionist   Primary Care Provider 
  Social Worker    Genetic Counselor 
   Nurse     (Metabolic) Laboratory Director 
   Patient Advocate    Other (Specify) _________________________________________________ 
 
 
 Part III. Satellite Clinics 
 
40. At how many satellite clinics do you treat metabolic patients? 
    One     Three or More 
  Two     Not Applicable 
 
41. On average, how many days per month do you practice in satellite clinics and treat patients with 
metabolic disorders? 
    1 – 2 days     11 – 20 days 
  3 – 5 days     More than 20 days 
  6 – 10 days    
 
42. Please check the top 3 reasons you practice in satellite clinics. 
  Geographically easier for patients   Uninsured patients 
  Satellite clinic specialization   Clinics affiliate with my employer (e.g. outreach facility) 
  Provider convenience   Personal belief 
  Contractual obligations   Other patient barriers (specify) __________________________ 
  Financial incentives of state mandate   Other (specify) _______________________________________ 
 
 Part IV. Home Visits 
 
43. How many days per month do you make home visits? 
    1 – 2 days     11 – 20 days 
  3 – 5 days     More than 20 days 
  6 – 10 days    
 
44. Please check the top 3 reasons why you make home visits. 
  Geographically easier for patients   Uninsured patients 
  Provider convenience   Personal belief 
  Contractual obligations   Other patient barriers (specify) ________________________ 




Thinking about an average patient in your practice diagnosed with a metabolic disorder detected on NBS from 
the time of positive screen through the first year of life… 
 
 Part V. Telemedicine  
 
45. Do you use remote patient monitoring, for example, remote diet recall or blood testing (i.e. heel sticks), 
to care for patients diagnosed with metabolic disorders? 
  No [SKIP TO question 47]     Yes 
 
46. How many days per month do you use the remote patient monitoring? 
    1 – 2 days     11 – 20 days 
  3 – 5 days     More than 20 days 
  6 – 10 days    
 
47. Do you use remote patient visits, for example through internet or phone conferencing, to care for 
patients diagnosed with metabolic disorders? 
  No [SKIP TO question 49]     Yes 
 
48. How many days per month do you use the remote patient visits? 
    1 – 2 days     11 – 20 days 
  3 – 5 days     More than 20 days 
  6 – 10 days    
 
49. Do you use other types of telemedicine (not remote patient monitoring or remote patient visits) to care 
for patients diagnosed with metabolic disorders? 
  No [SKIP TO question 51]     Yes 
 




51. Please check the top 3 reasons why you use telemedicine to care for patients with metabolic disorders. 
  Geographically easier for patients   Provider-to-provider communication about patient 
  Provider convenience   Personal belief 
  Contractual obligations   Other patient barriers (specify) ________________ 
  Financial incentives of state mandate   Other (specify) _____________________________ 
  Uninsured patients    
 
52. Could telemedicine be improved to assist you in the care of patients with metabolic disorders? 
  No      Yes (specify) _______________________________________________ 
      ________________________________________________ 
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Thinking about an average patient in your practice diagnosed with a metabolic disorder detected on NBS from 
the time of positive screen through the first year of life… 
 
 - ALL Providers -   
 
53. Thinking about the variety of practice models discussed here (satellite clinics, home visits, and 
telemedicine) that are used in the care of patients diagnosed with metabolic disorders, do you tend to see 
the same patients in only one setting or in a variety of settings?   
 
For example, do you utilize satellite clinic visits and telemedicine for the same patient and their family or is 
it more likely that you only see the patient and their family in one setting (for example, a satellite clinic) 




 Part VI. Medical Home 
 
54. Does your practice serve as a medical home to patients with metabolic disorders? 
  No      Yes [SKIP TO Part VII, question 57]    Don’t Know 
 
55. Does one of the other the patient's providers most often serve as a medical home? 
  No (Skip to Part VII, question 57)   Yes     Don’t Know (Skip to Part VII, question 57) 
 
56. Which of the patient’s other providers serves as the patient’s medical home? 
  Clinical Geneticist   Office/Administrative Manager 
  Dietitian/Nutritionist   Primary Care Providers 
  Social Worker   Genetic Counselor 
  Nurse   (Metabolic) Laboratory Director 
  Patient Advocate   Other (specify) _____________________________ 
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 Part VII. Challenges to Providing Care during the First Year of Life 
 
57. Please rate how challenging you find each of the following issues when providing care to patients 






 Not Very 
Challenging 
 Not at all 
Challenging 
 Don't Know 
/ Not 
Available 
Geographic distance between providers and 
patients/families 
         
Parental/familial compliance with treatment 
and management protocols 
         
Language barriers between providers and 
patients/families 
         
The adequacy of staffing at your clinic          
Unique protocols of insurance providers          
Availability of prescription medications 
and/or medical foods 
         
Ability to transition patients to hospital 
providers when they are admitted 
         
Having to take on other roles when providing 
care to patients/families 
         
Parent/family level of knowledge and 
awareness of their child's disorder 
         
Your own educational needs concerning 
metabolic disorders detected on NBS 
         
Having enough time to provide 
patients/families with all of the resources 
they need 
         
Lack of reimbursement for all of the care that 
patients/families need 
         
Communication between the State NBS or 
Follow-up Programs and providers 
         
Primary care providers' knowledge of 
metabolic disorders 





 Section 4: Education 
 
Thinking about an average patient in your practice diagnosed with a metabolic disorder detected on NBS from 
the time of positive screen through the first year of life… 
 
 Part I. Family 
 
58. Please check the top 3 things that you educate families about. 
  Basic information about the disorder (e. g. natural history, genetics)   
  Treatment/management for the disorder  
  Complications of the disorder  
  Prognosis of the disorder   
  Other services that the patient may need (e. g. support groups, community resources)   
  Insurance protocols pertaining to the disorder 
  Other (specify) _____________________________ 
 
59. On average, how many hours per month do you spend educating families?  
    Less than 1 Hour    6 - 10 Hours 
  1 - 2 Hours     11 – 20 Hours 
  3 - 5 Hours     More than 20 Hours 
 
60. Please select the 3 educational materials you use most frequently to teach families about their child’s 
disorder. 
    Pamphlets/resource binders   Other (Specify) _________________________________________________ 
  Parent advocates    None of the above 
  Support groups    Not Applicable 
   Websites 
 
61. Please rank the top 3 sources of information that families most frequently use to learn about their 
child’s metabolic disorder. 
    Websites   
  Previous experience with the Disorder (for example, another family member or friend with the disorder)  
  Pamphlets 
  NBS follow-up coordinator   
   Primary care providers 
  Other (Specify) _________________________________________________ 
  Not Applicable 
 
62. When you meet with families, how often would you say that the information they have about metabolic 
disorders when they come to your practice is accurate? 
    Always   
  Often  
  Sometimes 
  Rarely   
   Never 





 Part II. Relationships with Primary Care Providers 
 
Please answer the following questions about your relationships with primary care providers with regard to the 
treatment of patients diagnosed with metabolic disorders after a positive NBS and their families during the 
first year of life. 
 
 Answer ONLY if NOT a Primary Care Provider 
 
63. Do you personally work with primary care providers? 
  No       Yes 
 













 Don't Know / 
Not Applicable 
Primary care providers (PCPs) should 
participate on metabolic patient care 
teams 
           
PCPs often lack knowledge of the 
metabolic disorders detected on 
uniform screening panel 
           
PCPs should act as the medical home 
for metabolic patients in the first year 
of life 
           
PCPs should act as the liaison to the 
patient's insurance company 
           
 
65. Please rate how effective you believe each of the following methods would be to facilitate the sharing of 










 Don't Know / 
Not Applicable 
Periodic conference calls, including specialty 
and primary care providers, parents, others 
         
Active plan of care or action plan identifying 
current care needs, who will provide action, 
and when the action should be completed 
         
Written emergency care plan          
Consultation letter from the specialist 
describing findings, actions taken, and plans 
         
Condition-specific “fact sheet” with key 
information about the condition 
         
Shared or interoperable electronic health 
records 
         
Regular email communication with primary 
care providers 
         
Other (Specify)_______________________          
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Please answer the following questions about your relationships with primary care providers with regard to the 
treatment of patients diagnosed with metabolic disorders after a positive NBS and their families during the 
first year of life. 
 













 Don't Know / 
Not Applicable 
Communication occurs in both 
directions 
           
Communication provides easy to 
utilize, factual information about the 
child’s conditions, treatment, 
prognosis, medications, and co-morbid 
conditions 
           
Communication with primary care 
providers is a priority  
           
 
67. Please rank the top 3 ways you communicate with primary care providers after a patient has a routine 
visit? 
 1st   2nd  3rd 
Email      
Fax      
Phone Call      
Postal Mail      
Other ____________________      
 
 
 Answer ONLY if a Primary Care Provider 
 













 Don't Know / 
Not Applicable 
Communication occurs in both 
directions 
           
Communication does not explicitly 
define my role and responsibilities 
           
Communication provides easy to 
utilize, factual information about the 
child’s conditions, treatment, 
prognosis, medications, and co-morbid 
conditions 
           
Communication provides useful 
information about the emergency care 




 Section 5: Attitudes about Expanding the NBS Panel 
 












 Don't Know / 
Not Applicable 
Increasing the number of metabolic 
disorders on the NBS panel in my state 
would increase my caseload 
           
Expanding the number of metabolic 
conditions on the NBS panel would 
increase the time I spend treating 
patients. 
           
I may refer patients diagnosed with 
metabolic disorders added to the NBS 
panel to specialists in those disorders. 
           
I am concerned about being reimbursed 
for all of the care that I would provide 
to patients diagnosed with a disorder 
on an expanded NBS panel 
           
There are not currently enough 
practitioners educated to care for 
patients diagnosed with metabolic 
disorders on an expanded NBS panel 
           
I am concerned that there would not be 
evidence-based treatment protocols to 
care for children diagnosed with 
disorders added to the NBS panel 
           
Adding disorders to the NBS panel will 
make working with parents much more 
difficult 
           
I am excited to think about being able 
to treat children with metabolic 
diseases that would otherwise have not 
been detected at birth 
           
I am concerned that adding disorders to 
the NBS panel would result in a greater 
number of false-positives 





 Section 6: Best Practices 
 
70. This survey has asked you about processes of care and challenges to those processes for patients 
diagnosed with a metabolic disorder after a positive NBS and their families from the time of the screening 
through the first year of life.  Thinking about your experiences and practice, are there any models of care or 
other things that have improved the care that patients and their families receive that you would like to 





71. In this survey, we asked about the educational needs of patients’ families and primary care providers. 
 
How would you rate your need for additional education about metabolic disorders for the care of patients 
from birth to one year old? 
    I do not have any additional education needs.   
  I could use periodic updates about metabolic disorders and care practice.  
  I would appreciate frequent updates about metabolic disorders and care practices. 
 
72. What mode of education do you find most helpful? 
    I prefer to research information myself on the web 
  I prefer to have information mailed or emailed to me 
  I prefer to receive information at conferences or professional meetings 
 
 
 Section 7: Wrap-Up 
 
73. Thinking about the topics asked about here and any other concerns you have regarding the care of 
children with metabolic disorders and their families during the first year of life, what is the greatest 










 Debriefing Sheet 
 
Thank you for completing the survey! This page will further explain the purpose of the survey research you have just 
participated in. After you are finished viewing this page and have submitted your answers by clicking on the button at 
the bottom of the page, it is recommended you exit or quit your Web browser to eliminate the possibility (which varies 
depending on your computer and browser) that your responses could be viewed by hitting the "back" button. 
 
We would like to remind you that we will keep the information you provide confidential. Further, any potentially 
identifying information (e.g., zip code) will be used only for regional analysis. 
 
Because you have invested time in this study, you may have an interest in what we hope to find from your results. The 
purpose of this study is to examine the process of care for patients diagnosed with metabolic conditions that detected 
on newborn screen (NBS) from diagnosis to the first birthday. This study also examines the challenges and complexities 
of providing care to these patients and their families. 
If you have questions about this survey or would like a copy of the results when they are available, please email me or 
call me at the number below.  
 
Your participation, and that of your colleagues, is important for influencing ongoing policy discussions regarding the 
importance of genetic medicine.   
 
Thank you again for your interest and participation.  
 
Principal Investigator: Robert J. McGrath 
University of New Hampshire 
Department of Health Management and Policy 
327 Hewitt Hall 
4 Library Way 







Appendix B. Methodology Report 
 
 This appendix contains a brief summary of the dates and modes of survey distribution through 




The survey was distributed to potential respondents in two phases.  In the first stage, 
participants were recruited via electronic contact through the Genetic Service and Newborn Screening 
Regional Collaborative Groups (RCs).  The RCs were able to contact members of their listserv and those 
who received official RC newsletters.  Some RCs decided to work with local provider organizations and 
state NBS representatives in order to distribute the survey to the appropriate providers.  Due to privacy 
concerns, RCs did not want to share their provider lists with provider staff.  Because of lackluster 
response rates, a second stage of survey was employed.  During this stage, an effort was made to recruit 
providers directly through provider organizations, like the Society for the Inherited Metabolic Disorders 
(SIMD) and the National Society of Genetic Counselors (NSGC).  The method and dates of distribution 
are indicated below.   
 
Table Appendix B. Date and Method of Survey Distribution by Organization 
Organization Date Method 
New England Genetics 
Collaborative (NEGC) 
10/18/11 (via New England 
Consortium of Metabolic 
Programs) 
Email to Consortium Planning Group 
members 
10/28/2011 eNewsletter 
New York-Mid-Atlantic Consortium 
for Genetics and Newborn 
Screening Services (NYMAC) 
10/6/2011 Email 
1/20/2012 Email 
Southeast NBS and Genetics 
Collaborative (SERC) 
1/9/2012 email 
Region 4 Genetics Collaborative 10/17/2011 Email 
Heartland Regional Genetics and 
Newborn Screening Collaborative 
12/7/2011 Email to providers in 8 states 
1/10/2012 Email to additional providers 
Mountain States Genetics Regional 




Western States Genetic Services 
Collaborative (WSGSC) 
10/7/2011 Email to select group of providers 
11/15/2011 Email to providers contacted 10/7/11 
11/21/2011 Email to regional dietitians and genetic 
counselors 
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National Coordinating Center for 
the Regional Genetic and Newborn 
Screening Service Collaboratives 
(NCC) 
12/16/2011 Newsletter 
Pediatric and Clinical Genetics 
special interest group listserv of 
the National Society of Genetic 
Counselors (NSGC) 
1/20/2012 Listserv 
NBS mailing list (Newborn 
Screening Inquiry/Discussion List) 
(NBS@lists.UTSCSA.edu) 
1/23/2012 Listserv 
Society for Inherited Metabolic 
Disorders (SIMD) 
2/8/2012 Email 
American College of Medical 
Genetics (ACMG) Annual Clinical 
Genetics Meetings 
3/27-31/12 
Conference: flyer in conference bags, 
survey on conference computers, booth 
Genetic Metabolic Dietitians 
International (GMDI) Educational 
Conference 





 A total of 181 respondents viewed the survey.  Of those 181, 35 reported no information on the 
survey, 3 reported only one piece of information, and 5 reported 2 pieces of information.  Because they 
reported so little information, the decision was made to drop them from analyses.  Additionally, 21 
people who reported that they did not treat children diagnosed with metabolic conditions following a 
positive newborn screen were also removed from the sample.  Two additional cases were removed from 
the sample because the respondents reported a zip code outside of the United States (Canada).  The 
final sample size of usable reports for this report is 114. 
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Geographic Distance Between Providers and Patients/Families 42.86 (36) 51.19 (43) 4.76 (4) - - 1.19 (1) 
Parental/familial compliance with treatment and management 
protocols 
33.33 (28) 54.76 (46) 9.52 (8) 1.19 (1) - 1.19 (1) 
Language Barriers between Providers and Patients/Families 17.86 (15) 52.38 (44) 22.62 (19) 4.76 (4) - 2.38 (2) 
The Adequacy of Staffing at Your Clinic 17.86 (15) 35.71 (30) 33.33 (28) 8.33 (7) 1.19 (1) 3.57 (3) 
Unique Protocols of Insurance Providers 35.71 (30) 41.67 (35) 13.10 (11) 1.19 (1) 4.76 (4) 3.57 (3) 
Availability of Prescription Medications and/or Medical Foods 32.14 (27) 54.76 (46) 8.33 (7) 2.38 (2) 1.19 (1) 1.19 (1) 
Ability to Transition Patients to Hospital Providers when they are 
Admitted 
4.76 (4) 27.38 (23) 46.43 (39) 15.48 (13) 4.76 (4) 1.19 (1) 
Having to Take on Other Roles When Providing Care to 
Patients/Families 
13.10 (11) 52.38 (44) 26.19 (22) 7.14 (6) 1.19 (1) - 
Parent/Family Level of Knowledge and Awareness of their Child's 
Disorder 
17.86 (15) 64.29 (54) 15.48 (13) 2.38 (2) - - 
Your Own Educational Needs Concerning Metabolic Disorders 
Detected on NBS 
5.95 (5) 28.57 (24) 38.10 (32) 23.81 (20) 2.38 (2) 1.19 (1) 
Having Enough Time to Provide Patients/Families with All of the 
Resources They Need 
40.48 (34) 44.05 (37) 11.90 (10) 2.38 (2) 1.19 (1) - 
Lack of Reimbursement for All of the Care that Patients/Families 
Need 
61.90 (52) 27.38 (23) 4.76 (4) 1.19 (1) 3.57 (3) 1.19 (1) 
Communication between the State NBS or Follow-Up Programs and 
Providers 
3.57 (3) 15.48 (13) 35.71 (30) 41.67 (35) 2.38 (2) 1.19 (1) 
Primary Care Providers' Knowledge of Metabolic Disorders 25.00 (21) 47.62 (40) 22.62 (19) 1.19 (1) 2.38 (2) 1.19 (1) 
1
Row percentages are shown.       
 63
 





















General Perceptions               
  
Primary care providers (PCPs) should participate on 
metabolic patient care teams 
44.05 (37) 28.57 (24) 16.67 (14) 8.33 (7) - 1.19 (1) 1.19 (1) 
  
PCPs often lack knowledge of the metabolic disorders 
detected on uniform screening panel 
59.52 (50) 34.52 (29) 3.57 (3) - - 1.19 (1) 1.19 (1) 
  
PCPs should act as the medical home for metabolic patients 
in the first year of life 
39.29 (33) 25.00 (21) 15.48 (13) 14.29 (12) 1.19 (1) 2.38 (2) 2.38 (2) 
  
PCPs should act as the liaison to the patient's insurance 
company 
11.90 (10) 20.24 (17) 30.95 (26) 25.00 (21) 5.95 (5) 4.76 (4) 1.19 (1) 
Communication with PCPs               
  Communication occurs in both directions 21.43 (18) 38.10 (32) 9.52 (8) 20.24 (17) 4.76 (4) - 5.95 (5) 
  
Communication provides easy to utilize, factual information 
about the child’s conditions, treatment, prognosis, 
medications, and co-morbid conditions 
33.33 (28) 46.43 (39) 9.52 (8) 5.95 (5) 1.19 (1) 1.19 (1) 2.38 (2) 
  Communication with primary care providers is a priority  47.62 (40) 34.52 (29) 7.14 (6) 3.57 (3) - - 7.14 (6) 
1
Row percentages are shown. 
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Periodic conference calls, including specialty and primary care 
providers, parents, others 
16.67(14) 42.86 (36) 22.62 (19) 2.38 (2) 13.10 (11) 2.38 (2) 
Active plan of care or action plan identifying current care needs, 
who will provide action, and when the action should be 
completed 
39.29 (33) 47.62 (40) 3.57 (3) - 8.33 (7) 1.19 (1) 
Written emergency care plan 77.38 (65) 20.24 (17) - - 1.19 (1) 1.19 (1) 
Consultation letter from the specialist describing findings, 
actions taken, and plans 
63.10 (53) 28.57 (24) 5.95 (5) - 1.19 (1) 1.19 (1) 
Condition-specific “fact sheet” with key information about the 
condition 
45.24 (38) 42.86 (36) 8.33 (7) - 2.38 (2) 1.19 (1) 
Shared or interoperable electronic health records 41.67 (35) 39.29 (33) 3.57 (3) - 13.10 (11) 2.38 (2) 
Regular email communication with primary care providers 23.81 (20) 47.62 (40) 14.29 (12) 1.19 (1) 11.90 (10) 1.19 (1) 
Other 2.38 (2) 2.38 (2) - - 4.76 (4) 90.48 (76) 
1
Row percentages are shown. 
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Increasing the number of metabolic disorders on the NBS panel in 
my state would increase my caseload 
60.24 (50) 32.53 (27) 6.02 (5) - - 1.20 (1) - 
Expanding the number of metabolic conditions on the NBS panel 
would increase the time I spend treating patients. 
54.22 (45) 32.53 (27) 9.64 (8) 1.20 (1) - 1.20 (1) 1.20 (1) 
I may refer patients diagnosed with metabolic disorders added to 
the NBS panel to specialists in those disorders. 
15.66 (13) 14.46 (12) 20.48 (17) 15.66 (13) 19.28 (16) 14.46 (12) - 
I am concerned about being reimbursed for all of the care that I 
would provide to patients diagnosed with a disorder on an 
expanded NBS panel 
40.96 (34) 27.71 (23) 13.25 (11) 2.41 (2) 4.82 (4) 10.84 (9) - 
There are not currently enough practitioners educated to care for 
patients diagnosed with metabolic disorders on an expanded NBS 
panel 
62.65 (52) 19.28 (16) 14.46 (12) 2.41 (2) - - 1.20 (1) 
I am concerned that there would not be evidence-based treatment 
protocols to care for children diagnosed with disorders added to 
the NBS panel 
40.96 (34) 30.12 (25) 14.46 (12) 12.05 (10) 1.20 (1) - 1.20 (1) 
Adding disorders to the NBS panel will make working with parents 
much more difficult 
6.02 (5) 13.25 (11) 30.12 (25) 24.10 (20) 22.89 (19) 1.20 (1) 2.41 (2) 
I am excited to think about being able to treat children with 
metabolic diseases that would otherwise have not been detected 
at birth 
44.58 (37) 30.12 (25) 16.87 (14) 6.02 (5) - 1.20 (1) 1.20 (1) 
I am concerned that adding disorders to the NBS panel would 
result in a greater number of false-positives 
32.53 (27) 31.33 (26) 18.07 (15) 8.43 (7) 6.02 (5) 2.41 (2) 1.20 (1) 
1
Row percentages are shown. 
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